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1 INTRODUCTION 
1.1 Epidemiology and etiology of male infertility 
 
According to WHO definition, infertility is the inability of a sexually active, non-
contracepting couple to achieve spontaneous pregnancy in 1 year (WHO, 2000). 
About 15% of couples cannot achieve pregnancy within 1 year and seek medical 
treatment. In approximately 50% of these couples, a male infertility-associated factor 
was found together with abnormal semen parameters. Idiopathic infertility remains 
the most common diagnostic category of male infertility. The known causes of male 
infertility include varicocele, male genital tract infection, genetic causes such as 
chromosomal aberrations and Y chromosome deletions, endocrine disease, as well as 
post-testicular disorders such as obstruction (Bhushan et al., 2009a). 
      
Figure 1: Male infertility-associated factors and percentage of distribution (Jungwirth et al., 2012). 
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Figure 1 summarizes the etiology and percentage of distribution of male infertility. 
Urogenital infection and immunological factors account for 13% to 15% of all cases 
of male infertility (Jungwirth et al., 2012). The percentage may be still underestimated 
as idiopathic infertility may include part of these cases. 
 
1.1.1 Infection and inflammation associated male infertility 
 
Infection and inflammation of the male reproductive tract are common and also 
potentially correctable causes of male infertility (Organization, 2000; Weidner et al., 
1999). Infections of the male genital tract comprise urethritis, prostatitis, epididymitis, 
and epididymo-orchitis. Most of these diseases have a potential negative influence on 
spermatozoa at different levels of their development, maturation, transport, and 
function, and are thereby considered as male sub- or infertility (Bhushan et al., 2009a; 
Rusz et al., 2012; Weidner et al., 2013). Testicular inflammation could be induced by 
local or systemic infection of microorganisms, neoplastic processes (like seminoma, 
carcinoma in situ), chemical insults, physical factors such as trauma beside pre-
existenting testicular disorders of other origin (Schuppe and Meinhardt, 2005; 
Schuppe et al., 2008). Testicular infection and inflammation are detrimental for 
spermatogenesis. Osegbe (Osegbe, 1991) has reported that bacterial gonadal infection 
causes persistent azoospermia or oligospermia and leads to impairment of both testes 
as assessed by testicular biopsy and follicle-stimulating hormone examination, even 
though the infection is clinically confined in one testis. This clinical observation, 
suggesting persistent testicular inflammation and impairment of spermatogenesis after 
genital infection in spite of antibiotic treatment, is further supported by animal 
experiments (Demir et al., 2007; Ludwig et al., 2002; Pilatz et al., 2015). The 
prevalence of infection and inflammation in infertile males is difficult to determine 
due to subacute or chronic asymptomatic inflammation of the testis, and is therefore 
likely to be ignored (Schuppe et al., 2008). In addition, lymphocyte infiltration of the 
testis was found in more than 50% in asymptomatic patients with impaired fertility 
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(Schuppe et al., 2008). Therefore, infection- and inflammation-induced male 
infertility is likely to be underestimated, and further investigations need to be 
performed. 
 
1.1.2 Pathogens involved in genital tract infection 
 
   A plethora of microbes have been implicated to cause male genital tract infections, 
including a variety of bacteria, viruses, fungi, as well as protozoa (Keck et al., 1998; 
Ochsendorf, 2008). Urethritis is mainly caused by Chlamydia trachomatis, 
Ureaplasma urealyticum, and Neisseria gonorrhea (Schiefer, 1998), whilst the most 
common causes of bacterial prostatitis are Gram-negative bacteria, mainly strains of 
Escherichia coli (Naber and Weidner, 2000). It is a general agreement that 
epididymitis in men younger than 35 years is most likely caused by sexually 
transmitted pathogens such as Chlamydia trachomatis and Neisseria gonorrhea, while 
in men older than 35 years the disease is most commonly caused by enteric pathogens 
like Escherichia coli. This classification has been challenged recently by a study 
using state-of-the-art methods to investigate the etiology of acute epididymitis, 
suggesting that Escherichia coli is the predominant etiologic pathogen regardless of 
the patients’ age (Pilatz et al., 2014). Orchitis is not only caused by canalicular 
ascending pathogens, but also may be developed as a complication of systemic, 
predominantly viral infections such as mumps virus, due to hematogenous 
dissemination of the pathogen (Hviid et al., 2008; Rubin et al., 2015). Other viruses 
associated with the development of orchitis consist of Coxsackie virus types, Epstein-
Barr, influenza, varicella, and human immunodeficiency viruses (HIV) (Bachir and 
Jarvi, 2014; Schuppe et al., 2008). Uropathogenic Escherichia coli (UPEC) has been 
identified as the most frequently isolated pathogen in urinary tract infections, one of 
the most common bacterial infections of humans (Barber et al., 2013; Ulett et al., 
2013). This pathovars also accounts for epididymitis or epididymo-orchitis (Bhushan 
et al., 2009a; Pilatz et al., 2014). 
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1.1.3 Pathogenicity of uropathogenic Escherichia coli 
 
   UPEC strains possess a variety of virulence factors that enable them to cause 
diseases, including fimbrial adhesions, toxins, iron acquisition systems, and flagella 
amongst others (Emody et al., 2003; Nielubowicz and Mobley, 2010). The prototype 
RTX pore-forming toxin α-hemolysin (HlyA), frequently encoded by strains of 
UPEC, has distinct effects on host cells aside from outright lysis (Dhakal and Mulvey, 
2012; Wiles and Mulvey, 2013). It has been demonstrated that a sublytic 
concentration of HlyA can inhibit the AKT survival signaling pathway and activate 
the downstream transcription factor FOXO1 (Wiles et al., 2008). In addition, UPEC 
also utilize HlyA to attenuate immune response by inhibition of pro-inflammatory 
cytokine production (Hilbert et al., 2012). HlyA is associated with bacteria elicited 
thrombocytopenia by inducing degradation of Bcl-xL, a survival protein, in platelets 
(Kraemer et al., 2012). Moreover, HlyA triggers proteolysis of a number of host 
proteins to facilitate bacterial dissemination as well as to attenuate the host immune 
response (Dhakal and Mulvey, 2012). Recently, Gur et al showed HlyA-dependent 
NK cell killing is a strategy for UPEC to fight against NK cell-mediated host defense 
(Gur et al., 2013). Of note, HlyA also could induce inflammasome formation and 
pyroptosis of urothelial cells, which served as the first line of immune defense against 
intracellular UPEC (Nagamatsu et al., 2015). Collectively, apart from other virulence 
factors, HlyA is associated with various biological processes including bacterial 
dissemination, immune response suppression as well as inflammasome formation. 
 
1.2 Structure and function of the male reproductive system 
1.2.1 Structure and functions of the testis 
 
   The testis is comprised of two compartments, the seminiferous tubules and the 
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interstitium. Spermatogenesis takes place in the seminiferous epithelium where the 
spermatogonia undergo mitosis, followed by meiosis, ultimately divided into haploid 
round spermatids, and then transformed into spermatozoa. The later process termed 
spermiogenesis is characterized by removal of most cytoplasm of spermatid, 
condensation of DNA in the sperm head, tail formation, as well as the establishment 
of the acrosome. Apart from maturing germ cells, the seminiferous tubules also 
contain Sertoli cells surrounded by one or more layers of peritubular myoid cells. 
Sertoli cells not only play a key role in the regulation of spermatogenesis (Chen and 
Liu, 2015; Griswold, 1998), but also maintain immune tolerance primarily by forming 
the blood-testis-barrier (BTB) (Jiang et al., 2014; Kaur et al., 2014; Meinhardt and 
Hedger, 2011). Sertoli cells also engulf residual bodies from spermiogenesis as well 
as degenerated germ cells (Johnson et al., 2008). Peritubular myoid cells as smooth-
muscle-cell-like cell type surrounding the seminiferous tubular are responsible for 
tubular contractility and transport the immotile sperm (Albrecht, 2009; Mayerhofer, 
2013). The interstitial space is composed of Leydig cells, blood vessels, as well as 
immune cells. Leydig cells are a prominent cell type within the interstitium and 
produce androgens. Testosterone, the predominant androgen produced in testis, plays 
an important role in both spermatogenesis and the development and maintenance of 
male secondary sex characteristics. The immune cells in the interstitial space include 
macrophages, lymphocytes, mast cells, natural killer cells as well as dendritic cells, 
but no B cells. 
 
1.2.2 The epididymis, vas deferens and accessory sex glands 
 
   Spermatozoa released from seminiferous tubules reach the epididymis via the rete 
testis and a series of efferent ducts. Sperm maturation takes place in the epididymis, 
which is a long single highly coiled tubule (Eddy et al., 1985; Hinton and Palladino, 
1995). Sperm are stored prior to ejaculation in the cauda region of the epididymis. 
During ejaculation the sperm pass through the vas deferens, a muscularized duct, and 
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the urethra into the female reproductive tract. A genetic disease named congenital 
bilateral absence of the vas deference (CBAVD) is associated with male infertility due 
to the lack of both vas deferens and epididymis (Bombieri et al., 2011; Chan et al., 
2009). CBAVD as a genital phenotype of cystic fibrosis (CF) is caused by cystic 
fibrosis transmembrane conductance regulator (CFTR) gene mutations (Claustres, 
2005; Yu et al., 2012). In humans, the accessory sex glands include seminal vesicles, 
the prostate and bulbourethral glands. However, disparity is observed among different 
species. In cats and dogs, the seminal vesicles are not present, whereas rodents have 
well-developed seminal vesicles, coagulating glands, and prostate glands. 
Approximately 90% of semen originate from the accessory glands, the seminal 
vesicles in particular. 
 
1.3 Testicular immunology 
 
   During spermatogenesis, a plethora of autoantigens are expressed, which are 
tolerated by the testis. Hence, testes function as immune privileged organ to protect 
developing germ cells from a systemic autoimmune attack. The characteristic immune 
privilege of the testis is further supported by transplantation studies, in which 
histoincompatible allo- and xenografts transplanted into the interstitial space of the rat 
testis survived and prospered for indefinite periods of time (Bobzien et al., 1983; 
Head and Billingham, 1985; Head et al., 1983; Setchell, 1990). The BTB plays an 
important role in testicular immune tolerance by limiting the entry of leukocytes or 
immunoglobulins into the luminal compartment, thus preventing the contact between 
immune cells with auto-antigens. The BTB is formed by neighboring Sertoli cells via 
tight junctions (TJ), basal ectoplasmic specializations, gap and desmosome-like 
junctions, which divide the seminiferous tubule into a basal and apical (adluminal) 
compartment (Arck et al., 2014; Jiang et al., 2014). Other than the formation of the 
BTB, Sertoli cells also have inherent immune suppressive properties (Doyle et al., 
2012; Kaur et al., 2014). Numerous studies have shown that Sertoli cells protect co-
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transplanted grafts, such as adrenal glands, neurons, heart and pancreatic islets (xeno- 
or allo-transplantation) (Korbutt et al., 1997; Lim et al., 2009; Mital et al., 2010; 
Sanberg et al., 1996; Selawry and Cameron, 1993). As transplants are placed into the 
individual space, this protection cannot be attribute to the existence of a physical 
barrier (BTB) between neighboring Sertoli cells, but is mediated by Sertoli cell-
secreted factors, including anti-inflammatory proteins such as TGFβ, activin, 
complement, and proteinase inhibitors as well as indolamin-2,3-dioxygenase (IDO) 
(Fallarino et al., 2009; Lee et al., 2007; O'Bryan et al., 2005; Sipione et al., 2006; 
Suarez-Pinzon et al., 2000). In addition, Sertoli cells also inﬂuence B and T cell-
mediated cellular immune responses (Dal Secco et al., 2008; Mital et al., 2011). 
 
Although the testis is an immune privileged organ, it is still able to initiate an 
effective immune response or inflammatory reaction against bacteria or viral 
infection. Sertoli cells and testicular macrophages express Toll-like receptors (TLRs), 
which play an important role in activation of NF-κB or mitogen activated protein 
kinases (MAPKs) signaling pathways to mount a proinflammatory response (Bhushan 
et al., 2009b; Bhushan et al., 2008; Riccioli et al., 2006). Macrophages and NK cells 
in the testis are also involved in the innate immune response against bacterial or viral 
infection. In conclusion, the testis needs to maintain a delicate balance between 
suppression of the immune response to protect germ cells from auto-immune attack 
and the ability to mount an immune response against invading pathogens. 
 
1.4 Cell death pathways and immune response 
 
   The immune system responds to infection using various pathways, ranging from 
activation of pathways promoting survival to those eliciting cell death. The cell death 
pathways can be categorized into two classes i.e. regulated cell death (RCD) as well 
as accidental cell death (ACD) (Galluzzi et al., 2015). ACD is triggered by a variety 
of stimuli such as trauma, shearing, and potent detergent. ACD does not involve a 
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specific molecular machinery, and therefore cannot be prevented or modulated, 
revealing the structural disassembly of cells exposed to extremely harsh 
physicochemical conditions. On the contrary, the RCD involves a genetically encoded 
molecular machinery, and can be prevented or altered by the means of pharmacologic 
or/and genetic interventions targeting the key components of the machinery (Galluzzi 
et al., 2015). Caspases are a family of endoproteases, which play an essential role in 
the regulated cell death pathway (McIlwain et al., 2013). Therefore, regulated cell 
death pathways can be further categorized as caspase-dependent including apoptosis 
and pyroptosis or caspase-independent pathways such as necroptosis, mitochondria 
permeability transition-mediated regulated necrosis (MPT-RN), parthanatos, 
ferroptosis as well as NET release-associated cell death (NETosis) (Figure 2). Each 
pathway leads to different consequences (Galluzzi et al., 2015).  
 
 
Figure 2: Signaling pathways of regulated cell death(Linkermann et al., 2014). 
1.4.1 Apoptosis 
 
   The term apoptosis is derived from the ancient Greek word meaning “falling off”, 
and was coined by the Australian pathologist Kerr and colleagues in 1972 (Kerr et al., 
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1972). The morphological characteristics of apoptosis have been well established as 
cytoplasmic shrinkage, chromatin condensation initiating at the nuclear membrane 
(marginalization), which is then extending to the entire nucleus (pyknosis), followed 
by nuclear fragmentation (karyorrhexis). Moreover, little or no ultrastructural 
modifications of cytoplasmic organelles are seen, yet, plasma membrane blebbing 
(without losing its integrity until the final stages of the process), and cell membrane-
enclosed cell fragment formation (apoptotic bodies) are evident. The apoptotic cells 
are further engulfed by resident phagocytes in vivo (Kroemer et al., 2009). Apoptosis 
could be initiated by intrinsic and extrinsic stimuli (Favaloro et al., 2012), which are 
further illustrated in Figure 3. 
 
Figure 3: Schematic representation of the extrinsic and intrinsic pathways leading to apoptosis 
(Favaloro et al., 2012). 
 
1.4.1.1 Intrinsic apoptotic pathway 
 
   A variety of intracellular stresses such as oxidative stress, DNA damage, and 
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endoplasmic reticulum (ER) stress, can trigger intrinsic apoptotic cell demise. All 
these stresses converge at the mitochondria to induce mitochondria outer membrane 
permeabilization (MOMP), which further triggers the caspase activation cascade to 
cause apoptosis (Tait and Green, 2012). MOMP is stringently controlled by the B cell 
lymphoma-2 (BCL-2) family of proteins via protein-protein interactions (Westphal et 
al., 2014). The BCL-2 family is comprised of three groups of proteins based on their 
structure and function. The executioner proteins BCL-2 antagonist killer (BAK), and 
BCL-2 associated X protein (BAX) oligomerize in the mitochondria and permeabilize 
the mitochondria outer membrane to evoke MOMP. The anti-apoptotic members 
consist of BCL-2, BCL-w, BCL-XL, myeloid cell leukemia 1 (MCL-1) as well as 
BCL2 related gene A1. The BCL-2 homology (BH) 3 only proteins including BCL-2 
interacting domain death agonist (BID), BCL-2 interacting mediator of cell death 
(BIM), p53 upregulated modulator of apoptosis (PUMA), BCL-2 antagonist of cell 
death (BAD), BCL-2 interacting killer (BIK), BCL-2 modifying factor (BMF), 
harakiri (HRK) and Noxa can directly or indirectly activate the effector BCL-2 family 
members (Table 1) (Shamas-Din et al., 2013; Volkmann et al., 2014; Westphal et al., 
2014).  
 
 
Table 1: Binding profiles within BCL-2 family members (Shamas-Din et al., 2013). 
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   BID, BIM, and PUMA can directly activate the effector BAX, BAK to induce 
MOMP, whereas the sensitizers or derepressors containing BMF, BAD, BIK, HRK, 
Noxa, indirectly cause MOMP by disrupting the existing anti-apoptotic complex or 
occupying the protein binding sites in anti-apoptotic proteins (Moldoveanu et al., 
2014). Moreover, it has been reported that BIM preferentially activates BAX, whilst 
BID preferentially activates BAK (Sarosiek et al., 2013). The release of 
intermembrane space proteins including cytochrome c, second mitochondria-derived 
activator of caspases (SMAC), as well as high temperature requirement protein A2 
(HTRA2) into the cytosol, resulting from MOMP, activates the caspase cascade, 
ultimately causing apoptosis. 
 
1.4.1.2 Extrinsic apoptotic pathway 
 
   Extrinsic apoptosis can be induced by the binding of lethal ligands including Fas 
ligand (FasL), TNFα as well as TNF-related apoptosis inducing ligand (TRAIL), to 
the corresponding receptors such as Fas, TNFα receptor 1 (TNFR1) and TRAIL 
receptor (TRAILR) 1-2(Strasser et al., 2000; Wajant, 2002). Fas aggregation 
responding to the FasL binding recruits receptor interacting kinase 1 (RIP1), Fas 
associated protein with a death domain (FADD), cellular inhibitor of apoptosis 
proteins (cIAPs), c-FLIPs as well as pro-caspase 8 (or caspase 10). This 
supramolecular complex at the inner leaflet of the plasma membrane known as death-
inducing signaling complex (DISC) constitutes a platform to regulate caspase 8 or 
caspase 10 activation. The active caspase 8 can either catalyze and activate the 
downstream executor caspases (caspase 3, 6, 7) to induce apoptosis in a mitochondria-
independent way or truncate BID, which in turn causes MOMP and apoptosis, acting 
as a link between the intrinsic and extrinsic pathways. 
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1.4.2 Pyroptosis 
 
Pyroptosis was first introduced to describe Salmonella typhimurium-induced 
macrophage peculiar death by Brennan and Cookson in 2000 (Brennan and Cookson, 
2000). Pyroptosis is not limited to macrophages or as a result of bacterial infection 
(Bergsbaken et al., 2009). Pyroptosis shares the characteristics of both apoptosis and 
necrosis. Similar to necrosis, pyroptosis leads to cytoplasmic swelling, plasma 
membrane rupture, as well as release of the intracellular contents into the extracellular 
space. However, nuclear condensation and internucleosomal DNA fragmentation are 
also observed during pyroptosis, which is similar to apoptosis but not necrosis 
(Bergsbaken et al., 2009). Pyroptosis can be initiated by activation of caspase 1 or 
caspase 11, referred to as canonical and noncanonical inflammasomes, respectively, to 
combat infection (Lamkanfi and Dixit, 2014). Canonical inflammasomes convert 
procaspase 1 into active caspase 1 to mediate the maturation and secretion of 
proinflammatory cytokines IL-1β and IL-18. The noncanonical inflammasomes are 
triggered by activated caspase 11, inducing pyroptosis and release of IL-1α. The 
activation of caspase 11 can be induced by acylated lipid A, a component of the 
Escherichia coli lipopolysaccharide (LPS), as well as Salmonella typhimurium LPS, 
independent of the LPS receptor TLR4 (Hagar et al., 2013; Kayagaki et al., 2013). 
LPS is a key virulence factor of Gram-negative bacteria. Therefore, caspase 11 
activation is mainly provoked by Gram-negative bacteria (Broz et al., 2012; Case et 
al., 2013; Casson et al., 2013; Rathinam et al., 2012), but not by Gram-positive 
bacteria (Rathinam et al., 2012). Recently, it has been demonstrated that the UPEC 
virulence factor HlyA can trigger caspase 1- and caspase 11- (caspase 4 in human) 
mediated pyroptosis and release of IL-1α and IL-1β, indicating that caspase 1/caspase 
4-mediated pyroptosis plays a role in host defense against intracellular UPEC 
(Nagamatsu et al., 2015). The molecular mechanism underlying pyroptosis is still 
largely unknown. 
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1.4.3 Necroptosis 
 
   Necrosis has been considered as accidental cell death for a long time. Until recently, 
increasing evidence indicates that necrosis can occur in a regulated manner, referred 
to as necroptosis, and has a predominant role in inflammation and infections. 
Necroptosis could be triggered by multiple stimuli such as alkylating DNA damage 
and ligation of death receptors. A plethora of key molecular components of 
necroptosis has been identified, including receptor interacting kinase 3 (RIPK3), 
receptor interacting kinase 1 (RIPK1), as well as mixed lineage kinase domain like 
protein (MLKL). Upon TNFα binding to its receptor, the adaptor protein, tumor 
necrosis factor receptor type 1-associated death domain protein (TRADD) was 
recruited, further leading to an interaction between RIPK1 and RIPK3 via RIP 
homotypic interaction motif (RHIM). The formation of RIPK1 and RIPK3 complex, 
called necrosome, leads to activation of these kinases. The cellular inhibitor of 
apoptosis protein 1 (cIAP1) and cellular inhibitor of apoptosis protein 2 (cIAP 2) 
negatively regulate necroptosis by inhibiting RIPK1 and RIPK3 activation (McComb 
et al., 2012), whereas cyclindromatosis (CYLD) promotes necroptosis via 
deubiquitylation of RIPK1 (O'Donnell et al., 2011). MLKL was identified as a key 
RIPK3 downstream protein in necroptotic pathway. The phosphorylation of MLKL by 
RIPK3 is critical for necroptosis (Sun et al., 2012; Zhao et al., 2012). Of note, cells 
derived from MLKL-deficient mice are resistant to TNF-induced necroptosis, whereas 
a mutant of MLKL that mimics its active form directly induces cell death even in 
RIPK3 deficient cells. This study strongly suggested modification of MLKL is 
essential for propagation of the necroptosis pathway downstream of RIPK3 (Murphy 
et al., 2013). However, the mechanism of necroptosis execution is still controversial.  
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1.4.4 The influence of cell death pathway on inflammation 
 
   Regulated cell death plays an essential role in immune responses against infections. 
The different death pathways have different outcomes. The cytoplasmic constituents 
include a variety of danger associated molecular patterns (DAMPs) such as ATP, high 
mobility group box 1 (HMGB1), heat shock protein (hsp) 70 as well as hsp90, which 
can elicit inflammation by binding to the pattern recognition receptors (PRRs) of 
immune cells (Linkermann et al., 2014). In general, apoptotic cell death has been 
considered as non- or anti-inflammatory cell death pathway (Fadok et al., 1998; Voll 
et al., 1997). First of all, the cellular components are packaged into plasma-
membrane-bound vesicles, namely apoptotic bodies, therefore restricting DAMPs 
release. Secondly, phagocytes are attracted to engulf the apoptotic cells, leading to 
effective clearance of the apoptotic cells in vivo. In contrast, pyroptosis and 
necroptosis are pro-inflammatory death pathways (Bergsbaken et al., 2009; 
Pasparakis and Vandenabeele, 2015; Vanden Berghe et al., 2014). The release of 
DAMPs from cells undergoing pyroptosis and necroptosis can activate neighboring 
immune cells by binding to PRRs. Furthermore, pro-inflammatory cytokines 
including IL-1β, IL-33, and IL-18 secreted by cells undergoing pyroptosis or 
necroptosis can also trigger immune cell activation. 
 
1.5 FOXO transcriptional factors 
 
   The forkhead box O (FOXO) transcription factors consists of FOXO1 (also known 
as FKHR), FOXO3 (also known as FKHRL1), FOXO4 (AFX1), and FOXO6, which 
are homologs of the Caenorrhabditis elegans transcription factor DAF-16 (abnormal 
dauer formation-16) and Drosophila melanogaster dFOXO (Kenyon et al., 1993; 
Weigel et al., 1989). FOXOs mainly act as transcription factor by binding to the 
conserved consensus core recognition motif TTGTTTAC to regulate specific gene 
                                                                                                            INTRODUCTION 
- 22 - 
expression programs (Furuyama et al., 2000; Obsil and Obsilova, 2011). All the 
FOXO members share the same DNA-binding element. Therefore, they may play a 
redundant role in the regulation of target gene expression.  
 
1.5.1 Functions of FOXO transcription factors 
 
   The FOXO transcription factors regulate diverse gene expression programs, which 
are involved in multiple important biological processes, such as apoptosis, reactive 
oxygen species (ROS) detoxification, cell cycle arrest, as well as metabolism (Calnan 
and Brunet, 2008; Eijkelenboom and Burgering, 2013). 
 
1.5.1.1 Inducing Apoptosis 
 
   Apoptosis is a programmed death mode that includes intrinsic and extrinsic death 
pathways. It has been demonstrated that FOXOs induce apoptosis of hematopoietic 
cells deprived of growth factors by upregulation of BIM (Dijkers et al., 2000a; Essers 
et al., 2004). Gilley et al have found that FOXO3 directly activates the BIM promoter 
via two conserved FOXO binding sites to upregulate BIM expression and induce 
neuron apoptosis (Gilley et al., 2003). In addition to elevate BIM expression, PUMA, 
another BH3 only protein of the BCL2 family, is also under the control of FOXO3. 
FOXO-mediated PUMA upregulation is responsible for lymphoid cell apoptosis upon 
growth factor or cytokine withdrawal (You et al., 2006). Recently, it has been 
demonstrated that FOXO3 directly upregulates PUMA expression and cooperates 
with BIM to induce neuron death in response to toxic β-amyloid 1-42 (Akhter et al., 
2014). FasL, inducing extrinsic apoptosis, is also transcriptionally regulated by 
FOXO3 (Brunet et al., 1999). Moreover, TRAIL is a FOXO-regulated gene, which can 
initiate extrinsic apoptosis. The TRAIL promoter contains a FOXO binding site, and 
overexpression of FOXO1 and FOXO3 results in TRAIL upregulation and apoptosis 
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in prostate cancer cells, suggesting TRAIL is a direct target of FOXO3 (Modur et al., 
2002). Collectively, FOXO could induce apoptosis both in intrinsic and extrinsic 
pathways by increasing different sets of target gene expression. 
 
1.5.1.2 Cell cycle arrest and DNA repair 
 
   The cell cycle comprises the interphase phase that includes the G1 (gap phase 1), S 
(DNA synthesis), G2 (gap phase 2), and cell division or M phases (mitosis). The 
phase transitions of the cell cycle are under stringent control by the cooperative 
activity of specific cyclin-dependent kinases (CDKs), cyclins, and CDK inhibitors 
(CKIs) (Malumbres and Barbacid, 2009). CKIs can be divided into two classes, i.e., 
the Cip/Kip family including p21Cip1, p27Kip1, and p57Kip2, and the INK4 family 
containing p15INK4B, p16INK4A, p18INK4C, as well as p19INK4D. The 
association between the Cip/Kip family or the INK4 family with CDKs prevents the 
progression of the cell cycle. FOXOs primarily control the G1/S phase transition by 
regulation of cell cycle associated gene expression. p27Kip1 could be 
transcriptionally activated by FOXO4 to induce G1 cell cycle arrest (Medema et al., 
2000). Beside FOXO4, the activation of FOXO3 has also been shown to upregulate 
p27Kip1 (Dijkers et al., 2000b). In addition to upregulation of p27Kip1 expression, 
the expression of p21Cip1 is also increased through the activation of FOXOs and the 
TGF-β signaling pathway (Seoane et al., 2004). Other CKIs, the INK4 family, 
p15INK4B and p19INK4D are associated with FOXO-mediated G1cell cycle arrest. 
FOXOs can bind to promoter regions to induce transcription of p15INK4B and 
p19INK4D (Katayama et al., 2008). Additionally, FOXOs have also been 
demonstrated to impede cell cycle progression through regulating the expression of 
cyclin D, cyclin G, as well as the retinoblastoma protein family member p130 (Chen 
et al., 2006; Schmidt et al., 2002). Taken together, FOXOs are associated with G1 cell 
cycle arrest via regulating the expression of a set of genes involved in cell cycle 
progression. 
                                                                                                            INTRODUCTION 
- 24 - 
   DNA damage can activate the G2-M checkpoint, which triggers cell cycle arrest 
providing time for repair. FOXO3 directly increases Gadd45a expression via two 
FOXO binding sites in its promoter region. FOXO3 induces a delay in the G2-M 
phase in response to stress stimuli during which FOXO3 upregulate Gadd45a to repair 
damaged DNA (Tran et al., 2002).  
 
1.5.1.3 Oxidative stress resistance 
 
   Reactive oxygen species (ROS), including hydrogen peroxide (H2O2), superoxide 
(O2
•-) as well as hydroxyl radicals (•OH), are normal byproducts of cell metabolism or 
are generated to facilitate intracellular signaling (Storz, 2011). Oxidative stress occurs 
within cells when ROS are generated over the capability of antioxidants, or when cells 
are exposed to an extracellular source of ROS. FOXOs have been shown to play an 
important role in ROS detoxification (Droge and Kinscherf, 2008). Superoxide 
dismutase 2 (SOD2) is directly upregulated by FOXO3, which is an enzyme to 
detoxify ROS. The protection of cells from ROS by FOXO3-mediated SOD2 
upregulation antagonizes apoptosis caused by glucose deprivation (Kops et al., 2002). 
Catalase, which is another target gene of FOXO3, hydrolyzes hydrogen peroxide to 
water. It has been shown that FOXO3-mediated catalase upregulation results in an 
increase in both hydrogen peroxide scavenging and oxidative stress resistance 
(Nemoto and Finkel, 2002). Thus, FOXOs are able to detoxify ROS and thereby 
increase cell survival via cooperative regulation of both SOD2 and catalase.  
 
1.5.2 Posttranslational control of FOXOs 
 
   The activity of FOXOs is dynamically regulated in response to numerous 
intracellular or extracellular stimuli such as cytokine stimulation, growth factor 
withdrawal, and oxidative stress. Due to the functional importance of FOXO 
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transcription factors, their activity must be tightly regulated. One of the most 
important strategies is post-translational modification, including phosphorylation, 
acetylation, ubiquitination, methylation, and glycosylation.  
 
1.5.2.1 Phosphorylation of FOXOs  
 
   Like the homolog of the C. elegans transcription factor DAF-16 under the control of 
DAF-2, the FOXO transcription factors are also negatively regulated by the 
phosphatidylinositol-3-kinase (PI3K) and protein kinase B (PKB, also known as 
AKT) signaling pathway. AKT dependent phosphorylation of FOXOs on distinct 
threonine and serine residues promotes their interaction with 14-3-3 chaperone 
proteins and relocalization from nucleus to the cytosol as illustrated in Figure 3. The 
cytoplasm retention of FOXOs is dependent on 14-3-3-mediated masking of the 
FOXO nuclear localization signal (NLS) and reduction of their flexibility (Obsilova et 
al., 2005). 
 
Figure 4: Conserved AKT phosphorylation sites in FOXO proteins (Tzivion et al., 2011).  
 
   FOXOs are also substrates for other kinases. In contrast to the AKT signaling 
pathway, JNK-mediated phosphorylation of FOXOs drive their nuclear localization. It 
has been reported that FOXO4 can be phosphorylated by JNK at two different sites 
(threonine 447 and threonine 451) under oxidative stress, which causes its nuclear 
localization and activation (Essers et al., 2004). ERK has been reported to 
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phosphorylate FOXO3 resulting in its nuclear exclusion and degradation (Yang et al., 
2008). However, the AMP-activated protein kinase (AMPK) dependent 
phosphorylation of FOXO3 leads to its activation without influencing the subcellular 
localization (Greer et al., 2007).  
 
1.5.2.2 Other posttranslational modifications of FOXOs 
 
   The FOXOs are also subject to acetylation to regulate their transcriptional activity, a 
process controlled by histone acetyltransferases (HATs) and histone deacetylases 
(HDACs). The DNA binding activity of FOXOs are decreased after acetylation by 
CBP/P300, whilst the deacetylation of FOXOs by Sirtuin 1 (SIRT1) increases the 
ability of inducing cell cycle arrest as well as resistance to oxidative stress but inhibits 
the ability of triggering cell death (Brunet et al., 2004; Daitoku et al., 2004; van der 
Heide and Smidt, 2005). Nonetheless, Wang et al reported that deacetylation of 
FOXO3 by SIRT1 or SIRT2 causes Skp2-mediated FOXO3 polyubiquitination and 
proteasomal degradation (Wang et al., 2011). Polyubiquitination of FOXOs leads to 
their degradation (Huang et al., 2005), whereas monoubiquitination of FOXO4 has 
been demonstrated to induce its nuclear translocation and increase its transcriptional 
activity (van der Horst et al., 2006). Moreover, FOXO1 could be methylated by the 
protein arginine methyltransferase 1 (PRMT1) at arginine residues within a consensus 
site for AKT phosphorylation, thereby blocking AKT-mediated phosphorylation of 
FOXO1 (Yamagata et al., 2008). Recently, it has been demonstrated that FOXO3 can 
be methylated by the methyltransferase Set9 at lysine 270, resulting in the inhibition 
of its DNA binding activity and transactivation. This lysine methylation of FOXO3 is 
associated with FOXO3-mediated BIM expression and apoptosis in neurons under 
oxidative stress (Xie et al., 2012).  
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1.5.3 Regulation of FOXO transcriptional output by binding partners 
 
   The transcriptional output of FOXOs is highly context-dependent and cell- or tissue-
specific, which was proven by gene analysis of different cell types in FOXO1, 
FOXO3, and FOXO4 knockout mice (van der Vos and Coffer, 2011). To ensure cell 
type- or tissue-specific transcriptional outcomes, FOXOs utilize a number of binding 
partners to control the transcription specificity and activity, besides posttranslational 
modifications. 
 
   Androgen receptor (AR) is a member of the steroid/thyroid hormone receptor 
superfamily, which could be activated by androgens including testosterone and 
dihydrotestosterone (DHT) (Evans, 1988; Matsumoto et al., 2013). AR is comprised 
of an N-terminal domain (A/B domains), a DNA binding domain, a short hinge 
region, and a C-terminal ligand-binding domain. The activated AR inhibits FOXO1 
DNA-binding activity, thereby impairs the FOXO-mediated FasL expression, 
apoptosis as well as cell cycle arrest in prostate cancer cells. These effects are 
achieved by the interaction between the carboxyl terminus of FOXO1 and A/B 
domains as well as the ligand-binding domain of AR (Li et al., 2003). Meanwhile, the 
association between FOXO1 and AR suppresses the interaction of AR and p160 
coactivators and also inhibits AR-dependent gene expression (Ma et al., 2009). 
Moreover, androgens induce increased activity of an acidic cysteine protease, 
resulting in proteolysis of FOXO1, to protect prostate cancer cells from FOXO-
mediated cell death (Huang et al., 2004). FOXOs have also been shown to interact 
with another proteins such as PPARγ coactivator 1(PGC-1α), estrogen receptor α 
(ERα) and β-catenin (Daitoku et al., 2011; van der Vos and Coffer, 2008). In 
conclusion, by interaction with other binding partners, FOXOs crosstalk with other 
pathways to integrate upstream signals and affect its own activity. 
 
                                                                                                            INTRODUCTION 
- 28 - 
1.6 Epigenetic regulation of gene expression 
 
   In order to control target gene expression, the transcription factors need to bind 
specific DNA sequence elements. However, only the presence of a consensus DNA 
element is not sufficient to direct transcription factor binding to chromatin (Guertin 
and Lis, 2013). In eukaryotes, 145-147 base pairs of DNA are wrapped around a 
histone octamer consisting of two copies each of histone 2A (H2A), histone 2B (H2B), 
histone 3, and histone 4 to form the nucleosome, which restrict transcription factors 
access (Kornberg and Lorch, 1999; Luger et al., 1997). Therefore, dynamic chromatin 
remodeling processes are required for the initial steps in gene expression, and these 
processes are further regulated by epigenetic mechanisms such as DNA methylation, 
histone modifications, and small non-coding RNAs (microRNA) (Figure 5) (Relton 
and Davey Smith, 2010). 
Figure 5: Types of epigenetic modifications (Relton and Davey Smith, 2010). 
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1.6.1 Histone acetylation  
 
   In 1964, Allfrey and colleagues reported that histones can be modified by adding 
acetyl and methyl groups and their possible role in regulation of RNA synthesis 
(Allfrey et al., 1964). Since then, it has been well documented that histone acetylation 
facilitates the access of transcription factors to the DNA, and is thereby associated 
with actively transcribed genes (Khan and Khan, 2010; Shahbazian and Grunstein, 
2007; Verdin and Ott, 2014). Increased DNA accessibility to transcription factors is 
achieved by acetylation of histones through neutralizing the positive charge of lysine 
residues by acetyl groups, thereby weakening the charge-dependent interaction 
between histones and nucleosomal DNA as well as linker DNA or adjacent histones 
(Grunstein, 1997; Zentner and Henikoff, 2013). The lysine acetylation in histone tails 
is a dynamic reversible process controlled by two groups of enzymes: histone 
acetyltransferases (HATs) and histone deacetylases (HDACs) (Lee and Workman, 
2007). HATs can be categorized into three major families: the MYST family (named 
after its four founding members MOZ, Ybf2 (Sas3), Sas2, and Tip60), the Gcn5 
related N-acetyltransferase (GNAT) family, and CBP/p300 family (Berndsen and 
Denu, 2008), whilst HDACs can be classified into four classes (Barneda-Zahonero 
and Parra, 2012). More than 20 HATs have been identified, which acetylate histones 
via utilizing acetyl-coenzyme A (acetyl-CoA) as an essential cofactor to provide an 
acetyl group to the target lysine residue (Choudhary et al., 2014). Class I HDACs are 
comprised of 4 members HDAC1-3 and HDAC8, class II HDACs include HDAC4-7, 
HDAC 9 and 10, while class IV HDACs only consists of HDAC11. The class III 
HDACs, also known as Sirtuins, are comprised of Sirtuin 1-7. The class I, II, and IV 
HDACs are Zn
2+
-dependent enzymes, whereas class III HDACs need NAD
+ 
as a 
cofactor (Marks and Xu, 2009). 
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1.6.2 Other histone modifications 
 
   Histone 3 lysine 4 tri-methylation (H3K4me3) is enriched at the promoter region of 
actively transcribed genes (Barski et al., 2007; Heintzman et al., 2007; Koch et al., 
2007), a step considered as a hallmark of actively transcribed promoters (Hon et al., 
2009). Histone 3 lysine 36 tri-methylation (H3K36me3) is located in the body of 
genes and associated with actively transcribed genes (Kolasinska-Zwierz et al., 2009). 
In contrast, both histone 3 lysine 9 tri-methylation (H3K9me3) and histone 3 lysine 27 
tri-methylation (H3K27me3) are associated with epigenetic gene repression (Kooistra 
and Helin, 2012). The gene repression by H3K9me3 is involved in the recruitment of 
heterochromatin protein 1 (HP1) to induce heterochromatin formation (Fischle et al., 
2003), while H3K27me3 is catalyzed by the Polycomb repressive complex 2 (PRC2) 
and associated with repressed gene expression (Margueron and Reinberg, 2011). 
 
1.6.3 DNA methylation 
 
   DNA methylation is a biochemical process in which a methyl group from S-
adenosylmethionine is added to the C5 position of the pyrimidine ring of a cytosine 
base. In mammals, 60% to 90% of cytosines from cytosine-guanine (CpG) 
dinucleotides are methylated (Tucker, 2001), whereas the remaining unmethylated 
CpGs are clustered at certain regions, called CpG islands. In human and mice, CpG 
islands are present in the promoter regions of approximately 60% of genes (Antequera, 
2003). DNA methylation is a silencing epigenetic mark involved in a number of key 
biological processes such as genomic imprinting, X-chromosome inactivation, tissue 
specific gene repression, as well as carcinogenesis (Jones, 2012). In mammals, DNA 
methylation is catalyzed by a family of enzymes termed DNA methyltransferases 
(DNMTs) such as DNMT1, DNMT3A, and DNMT3B. DNMT1 is associated with 
maintenance of the pattern of DNA methylation after DNA replication (Hermann et 
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al., 2004), whilst DNMT3A and DNMT3B are involved in the establishment of de 
novo DNA methylation pattern during early development and gametogenesis (Okano 
et al., 1999). Aberrant DNA hypermethylation at the promoter region of tumor 
suppressor genes is associated with tumorigenesis.  
 
1.7 Aim of study 
 
   UPEC is the causative pathogen in the vast majority of both acute and chronic 
urinary tract infections in humans (Barber et al., 2013; Ulett et al., 2013). Due to the 
anatomical connection of the urinary tract to the genital tract in the male, UPEC can 
invade the ductal system of the male genital tract and cause urethritis, prostatitis, 
epididymitis or combined epididymo-orchitis.(Bhushan et al., 2009b; Ludwig, 2008). 
UPEC strains possess a plethora of virulence factors, which enable them to colonize 
and manipulate the host innate immune response. In recent years, the UPEC virulence 
factor α-hemolysin (HlyA) has been shown to deviate host survival signaling 
pathways including MAP kinases, NF-κB, AKT and inflammasome activation, as a 
strategy to escape the host immune response (Bhushan et al., 2008; Nagamatsu et al., 
2015; Wiles et al., 2008). It has been reported previously that HlyA can activate 
AKT/FOXO signaling, but the occurrence of apoptosis in bladder cells was not 
observed (Wiles et al., 2008). This is in agreement with in vivo studies from our group 
using an experimental epididymo-orchitis model indicating that UPEC infection 
causes death of testicular cells predominantly by necrosis instead of apoptosis (Lu et 
al., 2013). Furthermore, in our previous study it has been found HlyA is associated 
with long term impairment of semen parameters in genitourinary tract infection 
patients (Lang et al., 2013). 
 
    Therefore, the objective of this study was to investigate the molecular mechanism 
of UPEC mediated suppression of apoptotic cell death pathways as a means to 
facilitate bacterial propagation and silent chronification of disease. 
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2 MATERIALS AND METHODS 
2.1 Materials  
2.1.1 Chemicals 
Acetic acid Merck, Darmstadt 
Acrylamide 30% (w/v) Roth, Karlsruhe 
Agarose Invitrogen, Karlsruhe 
Bromophenol blue sodium salt Sigma-Aldrich, Steinheim 
Calcium chloride Merck, Darmstadt 
Dimethylsulfoxide Merck, Darmstadt 
Dithiothreitol (DTT) Roth, Karlsruhe 
D-Glucose Sigma-Aldrich, Steinheim 
Ethanol Sigma-Aldrich, Steinheim 
Ethidium bromide Roth, Karlsruhe 
Ethylene diaminetetraacetic acid disodium salt Merck, Darmstadt 
Formamide Merck, Darmstadt 
37% Formaldehyde solution Sigma-Aldrich, Steinheim 
Glycerol Merck, Darmstadt 
Glycine Sigma-Aldrich, Steinheim 
Glycogen Invitrogen, Karlsruhe 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid Roth, Karlsruhe 
Halt Phosphatase Inhibitor Cocktail Thermo Fisher Scientific, 
 Waltham 
Igepal CA-630 (NP-40) Sigma-Aldrich, Steinheim 
Magnesium chloride Merck, Darmstadt 
Magnesium sulfate Sigma-Aldrich, Steinheim 
LY294002  Cell Signaling Technology, 
 Danvers 
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β-Mercaptoethanol AppliChem, Darmstadt 
Methanol Sigma-Aldrich, Steinheim 
Non-fat dry milk Roth, Karlsruhe 
Paraformaldehyde Merck, Darmstadt 
Ponceau S Roth, Karlsruhe 
Potassium chloride Merck, Darmstadt 
Proteinase inhibitor cocktail Sigma-Aldrich, Steinheim 
Roti®-Phenol Roth, Karlsruhe 
Sodium acetate Roth, Karlsruhe 
Sodium chloride Sigma-Aldrich, Steinheim 
Sodium deoxycholate Roth, Karlsruhe 
N, N, N’, N’-Tetramethylethylenediamin Roth, Karlsruhe 
Tris (hydroxymethyl) aminomethane Roth, Karlsruhe 
Triton X-100 Sigma-Aldrich, Steinheim 
Tween-20 Roth, Karlsruhe 
 
2.1.2 PCR reagents  
DNase I Invitrogen, Carlsbad 
EDTA Invitrogen, Carlsbad  
dNTP Promega, Mannheim 
SuperScript® II Reverse Transcriptase Invitrogen, Carlsbad 
Oligo dT Promega, Mannheim 
RNase A Invitrogen, Karlsruhe 
Taq polymerase Promega, Mannheim 
SYBR green Bio-Rad, Munich 
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2.1.3 Enzymes for Sertoli cell and peritubular cell isolation  
 
Enzyme Company Catalogue No. 
Collagenase A  Roche Diagnostics, Mannheim 103586 
DNase I Sigma-Aldrich, Steinheim DN25 
Hyaluronidase Sigma-Aldrich, Steinheim H3506 
Trypsin Sigma-Aldrich, Steinheim T5226 
Trypsin inhibitor Sigma-Aldrich, Steinheim T6522 
Table 2: The list of enzymes used for Sertoli and peritubular cell isolation from rat testis. 
 
2.1.4 Antibodies 
 
Primary Antibody Manufacturer 
Catalogue   
No. 
Dilution 
(application) 
Rabbit anti p-AKT 
Cell Signaling 
Technology, Danvers, 
USA 
5012 1:1000 (WB) 
Rabbit anti AKT Santa Cruz, Dallas, USA sc-8312 1:500 (WB) 
Rabbit anti cleaved 
caspase 3 
Cell Signaling 
Technology, Danvers, 
USA 
9661 1:1000 (WB) 
Rabbit anti p-FOXO1 
(Thr24)/FOXO3a 
(Thr32) 
Cell Signaling 
Technology, Danvers, 
USA 
9464 1:1000 (WB) 
Rabbit anti p-FOXO1 
(Thr24)/FOXO3 
(Thr32)/FOXO4 (Thr28) 
Cell Signaling 
Technology, Danvers, 
USA 
2599 1:1000 (WB) 
Rabbit anti p-FOXO1 
(Ser256) 
Cell Signaling 
Technology, Danvers, 
USA 
9461 1:1000 (WB) 
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Rabbit anti p-FOXO3 
(Ser253) 
Cell Signaling 
Technology, Danvers, 
USA 
13129 1:1000 (WB) 
Rabbit anti FOXO1 
Cell Signaling 
Technology, Danvers, 
USA 
2880 
1:1000 (WB) 
1:100 (IF) 
 
Rabbit anti FOXO3a 
Cell Signaling 
Technology, Danvers, 
USA 
 
2497 
1:1000 (WB) 
1:100 (IF) 
Rabbit anti FOXO4 
Cell Signaling 
Technology, Danvers, 
USA 
9472 1:1000 (WB) 
Rabbit anti catalase 
Cell Signaling 
Technology, Danvers, 
USA 
8841 1:1000 (WB) 
Rabbit anti BIM 
Cell Signaling 
Technology, Danvers, 
USA 
2933 1:1000 (WB) 
 
Rabbit anti p27Kip1  
Cell Signaling 
Technology, Danvers, 
USA 
2552 1:1000 (WB) 
 
Rabbit anti p15INK4B 
Cell Signaling 
Technology, Danvers, 
USA 
4822 1:1000 (WB) 
 
Rabbit anti cyclin D1 
Cell Signaling 
Technology, Danvers, 
USA 
2926 1:1000 (WB) 
 
Rabbit anti cyclin D3 
Cell Signaling 
Technology, Danvers, 
USA 
2936 1:1000 (WB) 
Rabbit anti SOD2 
EMD Millipore, 
Billerica, USA 
AB10346 1:2000 (WB) 
Rabbit control IgG Abcam, Cambridge, UK Ab46540 1:100 (ChIP) 
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Rabbit anti-acetyl-
histone 4 
EMD Millipore, 
Billerica, USA 
06-866 
1:2500 (WB) 
1:100 (ChIP) 
Rabbit anti-acetyl-
histone 3 
EMD Millipore, 
Billerica, USA 
06-599 
1:2500 (WB) 
1:100 (ChIP) 
Rabbit anti-vimentin Santa Cruz, Dallas, USA sc-7557 1:100 (IF) 
Mouse anti β-actin Sigma-Aldrich, 
Steinheim, Germany 
A5441 1:2500 (WB) 
Table 3： Information for primary antibodies used for Western blotting (WB), immunofluorescence 
staining (IF) and chromatin immunoprecipitation (ChIP). 
 
Table 4: Secondary antibodies for Western blotting and immunofluorescence staining. 
   IgG: Immunglobulin G 
   HRP: Horseradish peroxidase  
 
2.1.5 Cell culture reagents 
Dulbecco s´ PBS (1×) w/o Ca
2+
 & Mg
2+
 Gibco, Darmstadt  
Fetal bovine serum Gibco, Darmstadt  
Penicillin/Streptomycin (100×) Gibco, Darmstadt  
RPMI 1640 medium Gibco, Darmstadt  
Trypsin/EDTA Gibco, Darmstadt  
 
2.1.6 Equipments 
Cell culture CO2 incubator Binder, Tullingen 
Confocal laser scanning microscope TCS SP2 Leica, Wetzlar 
Secondary antibody Manufacturer 
Catalogue   
No. 
Dilution 
Donkey anti rabbit IgG-Cy3 Chemicon, Hampshire, UK AP182C 1:1000 
Goat anti rabbit IgG -HRP 
Cell Signaling Technology,  
Danvers , USA 
7074 1:10,000 
Horse anti mouse IgG-HRP 
Cell Signaling Technology,  
Danvers , USA 
7676 1:10,000 
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Desktop centrifuge Biofuge Fresco Heraeus, Hanau 
Electronic balance SPB50 Ohaus, Giessen 
Fluorescent microscope Axioplan 2 Imaging Carl Zeiss, Göttingen 
FUSION-FX7 Advance PEQLAB, Erlangen 
Gel Jet Imager 2000 documentation system Intas, Göttingen 
Heat block DB-2A Techne, Cambridge 
Horizontal mini electrophoresis system PEQLAB, Erlangen 
Magnetic particle concentrator Invitrogen, Karlsruhe 
Microwave oven Samsung, Schwalbach 
Mini centrifuge Galaxy VWR International 
Mini-rocker shaker MR-1 PEQLAB, Erlangen 
Mixer Mill MM 300 Retsch, Haan 
MyiQ
TM
2 two-color real-time PCR detection system Bio-Rad, Munich 
NanoDrop ND 2000 Thermo Fisher Scientific,  
 Waltham 
PCR thermocycler Biozyme, Oldendor 
Potter S homogenizer B. Braun, Melsungen 
Power supply units PEQLAB, Erlangen 
Pre-cast gel system Invitrogen, Karlsruhe 
SDS gel electrophoresis chambers Consurs, Reiskirchen 
Semi-dry-electroblotter PEQLAB, Erlangen 
Thermo Shaker PEQLAB, Erlangen 
Vertical electrophoresis system PEQLAB, Erlangen 
Ultrasonic homogenizer Bandelin Sonopuls Bandelin, Berlin 
UV visible spectrophotometer Ultrospec 2100 Pro  Biochrom, Cambridge 
 
2.1.7 Miscellaneous 
Bio-Rad Protein Assay Bio-Rad, Munich 
DNA Ladder (100 bp) Promega, Mannheim 
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DAPI Vector, Burlingame 
Enhanced chemiluminescence (ECL) reagents Thermo Fisher Scientific, 
 Waltham 
Hybond ECL nitrocellulose membrane Amersham, Freiburg 
Protein size markers Thermo Fisher Scientific, 
 Waltham  
Sterile plastic ware for cell culture Sarstedt, Nümbrecht 
 
2.1.8 Primers 
 
   All primers were designed by using “Primer BLAST”, which is available online at 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/. Primer sequences and annealing 
temperatures for PCR analysis are listed in Table 4. All primers were purchased from 
MWG-Biotech (Ebersberg, Germany) and diluted in 1 × Tris-EDTA (pH 8.0) buffer to 
achieve 100 pmol/µl and stored as stock solution at -20°C. 
 
Gene  Primer Sequences Annealing 
Temperature 
Accession 
No. 
Amplicon Size 
(bp) 
β2M-fw 5 C´CGTGATCTTTC
TGGTGCTT3  ´
 
60°C 
 
NM_012512 
 
109 
β2M-rv 5 A´AGTTGGGCTT
CCCATTCTC3  ´
BIM-fw 5 A´GATACGGATC
GCACAGGAG3  ´
 
59.6°C 
 
NM_171989 
 
148 
BIM-rv 5 A´CCAGACGGAA
GATGAATCG3  ´
SOD2-fw 5 A´CCGAGGAGAA
GTACCACGA3  ´
 
59.6°C 
 
NM_017051 
 
148 
SOD2-rv 5 T´GGGTTCTCCAC
CACCCTTA3  ´
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Catalase-
fw 
5 G´CTCCGCAATCC
TACACCAT3  ´
 
59.6°C 
 
NM_012520 
 
104 
Catalase-rv 5 G´TGGTCAGGAC
ATCGGGTTT3  ´
Gadd45α-
fw 
5 G´GAGTCAGCGC
ACCATAACT3  ´
 
59.6°C 
 
NM_024127 
 
108 
Gadd45α-
rv 
5 G´GTCGTCATCTT
CATCCGCA3  ´
Table 5: Information on sequences of forward (fw) and reverse primers (rv) used in quantitative real-time 
PCR, annealing temperatures, gene accession numbers and amplicon sizes. 
 
2.2 Methods 
2.2.1 Animals 
 
   19-day old male Wistar rats (249~270 g) were purchased from Charles River 
Laboratories (Sulzfeld, Germany) and kept at 22°C with 12 h light: 12 h dark schedule 
and fed with standard food pellets and water ad libitum. This study was carried out in 
strict accordance with the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the German law of animal welfare. The protocol was approved 
by the Committee on the Ethics of Animal Experiments of the Regierungspraesidium 
Giessen, Giessen, Germany (permit number GI 20/23 –No. 16/2009 and GI 20/23–No. 
A31/2012). The rats were scarified by CO2 inhalation, and all efforts were made to 
minimize suffering. 
 
2.2.2 Bacterial strains and propagation 
 
   UPEC pyelonephritic strain prevalent in urinary tract infections: strain 536 (NCBI: 
NC_008253, CP000247) and the mutant with deletion of both α-hemolysin (hlyA) genes 
in the UPEC 536 strain (hlyA double mutant = UPEC 536 HDM) were obtained from 
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Prof. Ulrich Dobrindt (University of Muenster, Germany).  
   Uropathogenic E. coli strain UPEC 536 was propagated overnight on Columbia blood 
agar plates (Oxoid, Wesel, Germany). Fresh cultures were inoculated in LB medium and 
grown to early exponential phase (OD600 = 0.4~0.8) at 37°C in a shaker incubator. The 
concentration of viable bacteria was calculated using growth curves. Bacteria (2×10
9
 cfu) 
were centrifuged at 4,500 × g for 8 min at room temperature. The pellet was washed 
once at room temperature with PBS and diluted again in 10 ml saline or RPMI 1640 
medium. 
 
2.2.3 UPEC induced epididymo-orchitis model 
 
   The bacterial induced epididymo-orchitis model in male Wistar rat was previously 
established in our laboratory (Bhushan et al., 2008; Lu et al., 2013). Briefly, after 
successfully anaesthetizing the adult male Wistar rats (250~275g) with 50 mg/ml 
Ketamine and 2% Xylazine (v:v=7:3), the testis, epididymis and vas deferens were 
exposed by scrotum incision. One hundred µl of saline containing ~ 4×106 bacteria were 
injected into the vas deferens, close to the distal end of the epididymis. Sham operated 
rats were injected with saline. The rats were scarified and the testes were removed 
aseptically seven days post infection. Testes were snap frozen in liquid nitrogen and kept 
at -80°C for immunofluorescence and Western blot analysis. 
2.2.4 Isolation of Sertoli cells 
 
Medium 
 
PBS-A 
 500 ml PBS Dulbecco’s without Ca2+ and Mg2+  
 750 mg D-Glucose  
 5 ml 100 × Penicillin & Streptomycin 
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Trypsin-DNase-solution in PBS-A 
 10 ml PBS-A 
 25 mg Trypsin 
 200 µg DNase I 
 
Trypsin inhibiter-solution A in PBS-A  
 5 ml PBS-A 
 50 mg Trypsin inhibiter 
 
Trypsin inhibiter-solution B in PBS-A  
 10 ml PBS-A 
 25 mg Trypsin inhibitor 
 
Collagenase-Hyaluronidase-DNase-solution in PBS-A 
 10 ml PBS-A 
 10 mg Collagenase  
 10 mg Hyaluronidase  
 200 µg DNase I  
 
Hyaluronidase-DNase-solution in PBS-A 
 10 ml PBS-A 
 10 mg Hyaluronidase  
 200 µg DNase I  
 
 All enzyme solvents above were sterilized by passing through a 0.20 µm filter 
(SARSTEDT, Nuembrecht, Germany). 
 
Sertoli cell culture medium 
 500 ml RPMI-1640 medium with L-glutamine   
 5 ml 100 × Penicillin & Streptomycin   
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   Sertoli cells were isolated from 19-day old Wistar rats. Ten rats were killed by CO2 
inhalation. The abdomen was disinfected with 70% ethanol and twenty testes were 
collected aseptically via abdominal incision. Testes were rinsed by equal volume of 1% 
(w/v) iodine alcohol, and immediately washed two times with PBS. Next, testis was 
decapsulated by grasping one end with forceps, and cutting a small incision into the 
tunica albuginea at the other end of testis. The tubules were squeezed out by using 
closed forceps. 
 
   Seminiferous tubules were digested with 10 ml Trypsin-DNase-solution at 32°C in 
ashaking water bath (120 oscillations/min) for 3-6 min. When seminiferous tubules were 
properly separated, trypsin digestion was terminated by adding Trypsin inhibitor 
solution A (10 mg/ml) and B (2.5 mg/ml) sequentially. Seminiferous tubules were 
washed 9 times for 10 min with PBS-A to remove contaminating interstitial cells, 
followed by digestion with Collagenase-Hyaluronidase-DNase-solution at 32°C in a 
shaking water bath (120 oscillations/min) for 8-10 min. The digested tubules were 
observed under the microscope to check the length of tubules and smoothness of the 
surface of the tubules. If tubules shortened in length and edges appeared rough, the 
enzymatic digestion was stopped immediately. The rough edge and shortened length of 
tubules are both indicative of peritubular cell release. After digestion, tubular fragments 
were allowed to settle for 8 min. The supernatant with enriched peritubular cells was 
discarded. After 3-5 times washing with PBS-A, the remaining tubular fragments were 
further digested with 10 ml of Hyaluronidase-DNase-solution at 32°C in a shaking water 
bath (120 oscillations/min) for 3-5 min. The digestion of tubules was stopped when 
tubular fragments became very short and started to disintegrate to individual cells. The 
fragmented tubules were allowed to settle for 8 min, and washed 3 times with PBS-A to 
get rid of contaminating germ cells and peritubular cells. The Sertoli cell enriched 
fraction was dispersed by passing through an 18G needle 10 times using a 20 ml syringe, 
followed by spinning the cells down by centrifugation at 300 × g for 10 min. The cell 
pellet was resuspended in 40 ml RPMI 1640 medium, which was further passed through 
70 µm nylon filter (BD Biosciences, Heidelberg, Germany) to remove the undigested 
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tubular fragments. 4 × 106 cells/well were seeded in 6-well plates and incubated at 32°C 
with 5% CO2. Cell numbers were adjusted accordingly for culture in 12-well and 24-
well plates. The hypotonic shock treatment was performed on the 3rd day of culture to 
eliminate contaminating germ cells. Briefly, Sertoli cells were rinsed two times with 
PBS and incubated with 20 mM Tris-HCl (pH 7.5) for 1 min. Subsequently, cells were 
washed twice with PBS and cultured for at least 1 day in RPMI 1640 medium. On the 
4th day, Sertoli cells were ready for experiments.    
 
   Purity of Sertoli cell preparation was estimated > 95% by immunofluorescence using 
antibody directed against vimentin. 
 
2.2.5 cDNA synthesis and quantitative real-time PCR 
2.2.5.1 Isolation of RNA 
 
   Total RNA was extracted from Sertoli cell samples by using the PureLink® RNA Mini 
Kit (Invitrogen, Carlsbad, USA). After the indicated time periods of UPEC infection, 
Sertoli cells were collected in 600 µl RLT buffer (containing 1% β-Mercaptoethanol) by 
using cell scrapers. The cell lysates were passed through a 21G needle with a 1 ml 
syringe for 5~10 times to avoid cell clumps, subsequently frozen in liquid nitrogen and 
then stored at -80°C for the day of isolation. Otherwise, the lysate was directly mixed 
thoroughly with 1 volume of 70% ethanol. Up to 700 µl of the mixture was transferred 
to spin cartridge (with the collection tube) for centrifugation at 12,000 × g for 15 sec. 
The flow-through was discarded and the spin cartridge was reinserted into the collection 
tube. This process was repeated until the entire sample was processed. Wash buffer 1 
(700 µl) was added to the spin column to wash column membrane by centrifugation at 
12,000 × g for 15 sec. The collection tube was replaced with a new collection tube and 
wash buffer 2 (500 µl) was added to the column. The spin column was centrifuged for 
15 sec at 12,000 × g and the flow through was discarded. This process was repeated 
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again followed by a centrifugation at 12,000 × g for 2 min to dry the membrane. The 
RNeasy spin column was placed in a new 1.5 ml collection tube, and 30~40 µl RNase-
free water was directly added to the column membrane. After incubation for 1 min, the 
RNA was eluted by centrifugating at 16,060 × g for 2 min. RNA concentration of each 
sample was measured by NanoDrop.  
 
2.2.5.2 DNA digestion  
 
   Prior to RT-PCR amplification, putative contamination of genomic DNA from each 
RNA sample was eliminated by DNase I (Invitrogen, Carlsbad, USA) treatment. RNA 
from each sample (2.5 µg) was treated with 2 µl DNase I at room temperature for 15 
min in the reaction mixture given below. Two µl of 25 mM EDTA (pH 8.0) solution was 
added to each sample and subsequently heated at 65°C for 10 min to inactivate DNase I.  
 
DNase digestion reaction mix: 
 
 
 
 
 
   Each DNase I digested RNA sample was amplified by standard PCR to detect the 
expression of a housekeeping gene (β-actin). The absence of PCR product was verified 
by agarose gel electrophoresis and ethidium bromide (EB) staining to confirm the 
samples were free of DNA contamination. 
 
2.2.5.3 Reverse transcription  
 
   The DNase I digested RNA sample was reverse transcribed by using SuperScript® II 
Reverse Transcriptase (Invitrogen, Carlsbad, USA). For each reaction, 2.5 µg of RNA 
Component Volume 
2.5 μg RNA X μl 
DNase I (1 U/μl) 2.0 μl 
10 × DNase I buffer 2.0 μl 
RNase free water to 20 μl 
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was mixed with 2 µl of Oligo (dT) 15 Primer and 2 µl dNTP (10 mM), subsequently 
denatured at 65°C for 5 min.  
 
Denaturation of RNA and primer annealing: 
Component Volume 
2 μg of DNase I digested RNA  20 μl 
Oligo dT15 2 μl 
dNTP Mix (A,C, G and T, each 10 mM) 2 μl 
   The denatured samples were snap chilled on ice. The RT mix was prepared as below 
prior to mix with the denatured RNA samples. 
 
RT mix: 
Component  Volume  
5 × first strand buffer buffer  8 μl  
DTT (0.1M)  4 μl  
RNase-free water  4 μl  
   The samples were preheated at 42°C for 2 min, and 1 μl of reverse transcriptase 
(SuperScript® II Reverse Transcriptase, 200 U/μl) was added to each sample. The 
reaction mix was incubated at 42°C for 50 min, followed by inactivation of reverse 
transcriptase by heating samples at 70°C for 15 min. And cDNA samples were stored at 
-20°C. 
 
2.2.5.4 Quantitative real-time RT PCR (qRT-PCR) 
 
   qRT-PCR is a widely used laboratory technique based on the standard polymerase 
chain reaction (PCR) to amplify and simultaneously detect or quantify a targeted cDNA 
molecule. Besides the general principle of PCR, the key feature of qRT-PCR is that the 
amplified product is detected and measured as the reaction progresses, which is in "real 
time". The real-time quantitative detection of PCR products can be achieved by adding to 
the reaction a fluorescent molecule, which reports an increase in the amount of DNA with 
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a proportional increase in fluorescence signal. The fluorescent molecule could be non-
specific fluorescent dyes (such as SYBR green used in this project) that intercalate with 
double-stranded DNA or fluorescently labeled sequence-specific DNA primers or probes. 
The fluorescence signal can be monitored and recorded in a thermocycler, which is used 
to measure the threshold cycle (Ct) value. The Ct value is inverse proportional to the 
initial amount of cDNA. 
 
   To measure SOD2, BIM, catalase, and Gadd45α expression, primer pairs were designed 
by “Primer BLAST” and synthesized by Eurofins MWG Operon. The appropriate 
annealing temperatures were determined by gradient PCR. A typical 25 µl qRT-PCR 
reaction mix was used as follows.  
 
 
 
 
 
 
 
   Real-time PCR was performed in duplicate to measure the expression of target genes 
by using the iCycler iQ
®
 System (Bio-Rad, Munich, Germany) according to the 
manufacturer’s procedure. PCR amplification was carried out at 95°C for 8 min, and 
then cycled 45 times at 95°C for 20 sec, at annealing temperature (see Table 4) for 30 
sec, and at 72°C for 30 sec. 
 
   The specificity of the PCR product was confirmed by melt curve examination. Real-
time RT PCR results were analyzed with the delta delta threshold cycle method using β-
microglobulin as an internal standard to normalize the amount of mRNA. Data were 
presented as relative expression (RE): RE= 2ΔCt UPEC-ΔCt Ctrl, ΔCt=Cttarget gene-Ctβ2M.  
Component Volume per reaction 
cDNA 1 µl 
2 × iQ SYBR green supermix 12.5 µl 
Forward and reverse primer mix (10 pM/µl) 1 µl 
DNase/RNase free water 10.5 µl 
Total volume 25 µl 
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2.2.5.5 Agarose gel electrophoresis  
 
6 × gel loading buffer with Bromophenol blue  
 0.25% (w/v) Bromophenol blue  
 30% Glycerol in H2O 
50 × TAE electrophoresis buffer (1L, pH 8.0)  
 242 g of Tris base  
 57.1 ml of Glacial acetic acid  
 100 ml of 0.5 M EDTA  
1× TE buffer 
 10 mM Tris-HCl pH 8.0  
 1 mM EDTA  
 
2.2.6 Immunoblotting 
2.2.6.1 Buffers and solutions 
 
30% Acrylamide solution 
 Acrylamide/Bisacrylamide = 37.5:1 
RIPA buffer  
 10 mM Tris-HCl pH 7.4 
 150 mM NaCl 
 0.25% NP-40 
 1% Triton X-100 
 2 mM EDTA  
 1 mM PMSF * 
 1 × Proteinase inhibitor cocktail (Sigma-Aldrich, Steinheim, Germany)* 
 1 × Halt Phosphatase Inhibitor Single-Use Cocktail (Thermo Fisher Scientific, 
Waltham, USA)* 
* 
Added fresh just before cell lysis  
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Protein gel sample loading buffer 
 50 mM Tris-HCl; pH 6.8 
 2% SDS 
 10% Glycerol 
 1% β-Mercaptoethanol  
 12.5 mM EDTA 
 0.02% (w/v) Bromophenol blue  
10 × Phosphate buffered saline (PBS)  
 4 g KCl 
 4 g KH2PO4 
 160 g NaCl 
 23 g Na2HPO4 * H2O 
 Dissolved in 1L H2O, pH to 7.4 with HCl 
10 × Tris buffered saline (TBS) 
 24.2 g Tris base 
 80 g NaCl 
 Dissolved in 1L water, pH to 7.4 with HCl 
Washing buffer TBS/T 
 1 × TBS  
  0.1% (v/v) Tween-20 
Blocking buffer 
 100 ml 1 × TBS  
 0.1 ml Tween-20 
 5 g Non fat dry milk 
10 × Electrophoresis buffer (pH 8.3) 
 30.3 g Tris base 
 144 g Glycine 
 10 g SDS 
 Dissolved in 1L water, set pH to 8.3 with HCl 
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Stripping buffer 
 6.25 ml 1 M Tris-HCl (pH 6.8) 
 2 ml 10% SDS 
 700 µl β-Mercaptoethanol* 
 Make volume up to 100 ml with water 
 * added freshly just before stripping of membrane 
Cathode buffer 
 25 mM Tris 
 40 mM 6-amino-hexanoic acid  
 20% (v/v) Methanol  
10 × Anode buffer 
 300 mM Tris 
 20% (v/v) Methanol 
1 × Anode buffer 
 30 mM Tris 
 20% (v/v) Methanol  
 
Separating gel: 
 
 7.5%* 10%* 12.5%* 15%* 
Water 4.85 ml 4.01 ml 3.17 ml 2.35 ml 
1.5 M Tris-HCl pH 8.8 2.5 ml 2.5 ml 2.5 ml 2.5 ml 
10% (w/v) SDS 100 µl 100 µl 100 µl 100µl 
Acrylamid 2.5 ml 3.34 ml 4.17 ml 5 ml 
10% (w/v) APS
** 
50 µl 50 µl 50 µl 50 µl 
TEMED 5 µl 5 µl 5 µl 5 µl 
Total 10 ml 10 ml 10 ml 10 ml 
 
Stacking gel: 
 
 
 
 
 
 4%* 
Water 3 ml 
0.5 M Tris-HCl pH 6.8 1.25 ml 
10% (w/v) SDS 50 µl 
Acrylamide 0.65 ml 
10% (w/v) APS
** 
25 µl 
TEMED 5 µl 
Total 5 ml 
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* Separating gels with different percentages were used according to the molecular 
weight of target proteins (based on 37.5:1 acrylamide/bisacrylamide ratio). 7.5% gel: 
250~120 kDa; 10% gel: 120~40 kDa; 12.5% gel: 40~15 kDa; 15% gel: < 20 kDa. 
** Ammoniumpersulfate (APS) was prepared fresh before each experiment. 
 
2.2.6.2 Western blotting 
 
   Following treatment as indicated in respective figures, Sertoli cells were washed twice 
with PBS and then collected into RIPA lysis buffer (10 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 0.25% NP-40, 1% Triton X-100, 2 mM EDTA and 1 mM PMSF) supplemented 
with proteinase inhibitor cocktail and Halt Phosphatase Inhibitor Single-Use Cocktail. 
The concentrations of protein in cell lysates were determined by the Bradford Method 
(Bio-Rad, Munich, Germany). Twenty µg protein of each sample were fractioned on 
SDS-polyacrylamide gel and separated proteins were electrophoretically transferred onto 
a 0.2 µm pore size nitrocellulose membrane (Hybond
TM
 ECL
TM
, GE Healthcare, 
Cambridge, UK) by using a PerfectBlue
TM
 semidry electroblotter. Following blocking in 
5% non-fat milk in Tris-buffered saline (TBS) with 0.1% Tween (TBS-T) for 1 h at 
room temperature, the membranes were probed with primary antibodies (Table 2) 
diluted in BSA and incubated overnight at 4°C. After rinsing three times with TBS-T, 
membranes were incubated with HRP-conjugated anti-mouse or anti-rabbit antibody 
(Table 3) for 1 h at room temperature. Subsequently, the membranes were rinsed again 
for three times. The blots were developed by enhanced chemiluminescence (Thermo 
Fisher Scientific) and visualized by using Fusion Imaging system. 
2.2.6.3 Reprobing of membrane 
 
   Membranes were incubated with stripping buffer at 60°C for 3 min. The membranes 
were washed again three times with a large volume of TBS/T and blocked with blocking 
buffer for 1 h at room temperature. Subsequently, the antibody decoration and 
visualization were performed as described above. 
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2.2.7 Immunofluorescence staining 
 
   Sertoli cells were grown on glass coverslips in 12-well cell culture plates (BD 
Biosciences, Heidelberg, Germany) and infected with UPEC for 4 h. Cells were then 
washed two times with ice cold PBS, ﬁxed with 4% precooled paraformaldehyde for 30 
min and subsequently permeabilized with 0.2% Triton X-100 in PBS for 15 min. After 
blocking the cells with 5% normal goat serum and 5% BSA solution for 1 h, cells were 
incubated overnight at 4°C with the indicated primary antibodies. Next day, the samples 
were rinsed thoroughly and then incubated with Cy3-labeled secondary antibodies 
(Chemicon, Hampshire, UK) for 1 h. Nuclei were counterstained with Cy5-conjugated 
TO-PRO-3 dye (Invitrogen, Carlsbad, USA). Images were visualized using TCSSP2 
confocal laser-scanning microscope. 
 
   Frozen tissue sections (10 μm) were fixed with ice cold methanol and then 
permeabilized with 0.2% Triton X-100 in PBS for 15 min. Following blocking with 5% 
BSA and 5% normal horse serum solution for 1 h, the sections were incubated with 
indicated primary antibodies overnight at 4°C. After three rinses, the sections were 
incubated with Cy3-labeled secondary antibodies for 1 h and mounted with Vectashield® 
mounting medium containing DAPI (Vector Laboratories, Burlingame, USA). Images 
were captured with the Fluorescence Microscope Axioplan 2 imaging system. 
 
2.2.8 FOXO DNA-binding activity assay 
 
   Sertoli cells were treated with UPEC for 2 and 4 hours. Nuclear extracts were isolated 
using the Nuclear Extract Kit (Active Motif, La Hulpe, Belgium) according to the 
manufacturer’s instruction. The cells were washed twice with ice-cold PBS and scraped 
into PBS containing proteinase inhibitor cocktail. The suspension was centrifuged at 500 
rpm at 4°C for 5 min. The cell pellet was resuspened in 100 µl hypotonic buffer, mixed 
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thoroughly, and incubated on ice for 15 min. Detergent (5 µl) was added and vortexed at 
the highest setting for 10 sec. The suspension was centrifuged at 14000 × g at 4°C for 30 
sec. The nuclear pellet was suspended in 30 µl complete lysis buffer and vortexed 10 sec 
at the highest setting. The samples were incubated on a rocking platform at 4°C for 30 
min. After vortexing for 30 sec at the highest setting, the samples were centrifuged at 
14000 × g at 4°C for 10 min. The protein concentration was determined by the Bradford 
Method. DNA-binding activity of nuclear FOXO1 was measured using the Trans-AM 
FKHR Kit (Active Motif) as instructed by the manufacturer. Nuclear protein (10 µl) and 
complete binding buffer (40 µl) were added to each well on the plate. Nuclear extract (5 
µg, provided by the manufacture) was diluted in 10 µl of complete lysis buffer and used 
as positive control. Complete lysis buffer (10 µl) was used as blank. Following 
incubation for 1 h at room temperature with mild agitation, each well was washed three 
times with 200 µl of wash buffer. The FOXO1 antibody was added to each well and 
incubated for 1 h at room temperature. After three washes with wash buffer, 100 µl of 
HRP-conjugated secondary antibody were added. Following 1 h incubation at room 
temperature and 4 × wash with wash buffer, 100 µl of developing solution were added to 
each well. The plate was incubated for 2-10 min at room temperature in the dark. Stop 
solution (100 µl) was added to each well, and mixed properly by gentle tapping of the 
plate. The color of the solution in the wells should change from blue to yellow. The 
absorbance was recorded at 459 nm with a reference wavelength of 655 nm by using a 
BioSource International ELISA reader and corresponding software. 
 
2.2.9 Chromatin Immunoprecipitation Assay 
 
   ChIP assay was performed using Chromatin Immunoprecipitation Assay Kit (EMD 
Millipore, Billerica, USA) according to the manufacturer’s instruction. After UPEC or 
mock treatment, Sertoli cells were washed twice with ice cold PBS and incubated in 
RPMI 1640 medium containing 1% formaldehyde for 10 min at room temperature to 
cross link the protein with DNA. Glycine (1×) was added to quench unreacted 
                                                                                          MATERIALS AND METHODS 
- 53 - 
 
formaldehyde. Sertoli cells were washed two times with ice cold PBS, and cells were 
collected into PBS containing proteinase inhibitor cocktail. The cells were centrifuged at 
800 × g at 4°C for 5 min, supernatants were discarded and cell pellets were lysed with 
0.5 ml cell lysis buffer containing proteinase inhibitor cocktail. The cells were incubated 
on ice for 15 min with vortexing at every 5 min. The cell suspension was centrifuged at 
800 × g at 4°C for 5 min. The cell pellet was resuspened in 0.5 ml nuclear lysis buffer 
for further release of chromatin. The extracted chromatin was sonicated in 0.5 ml 
nuclear lysis buffer for sixteen rounds for 10 s each with an interval of 2 min using an 
Ultrasonic homogenizer Bandelin Sonopuls at 50% intensity, to generate fragments of 
200-1000 bp of DNA. The entire sonication procedure was performed in ice. The 
sonicated chromatin was spun at 1000 × g at 4°C for 10 min to remove insoluble 
material. Five µl sheared chromatin were analyzed by agarose gel electrophoresis to 
confirm the size of the DNA fragments. One hundred µl sheared chromatin were diluted 
in 400 µl dilution buffer containing proteinase inhibitor cocktail, and 
immunoprecipitated using rabbit polyclonal IgG anti-acetyl-histone 3 and rabbit 
polyclonal IgG anti-acetyl-histone 4 antibodies. Anti-rabbit IgG antibody was used as 
negative control. Ten µl of each sheared chromatin and dilution buffer mixture were 
used as input and stored at 4°C. The sheared chromatin, indicated antibodies and protein 
A & G magnetic beads were mixed and incubated at 4°C with rotation overnight. The 
beads were separated by using magnetic particle concentrator. The protein A & G beads-
antibody/chromatin complex was resuspened in low salt immune complex wash buffer 
and incubated for 3-5 min on a rotating platform followed by magnetic clearance and 
removal of the supernatant fraction. The same procedure was repeated using high salt 
immune complex wash buffer, LiCl immune complex wash buffer and TE buffer in 
sequence. The washed protein A & G beads-antibody/chromatin complex was incubated 
in 100 µl ChIP elution buffer containing 1 µl proteinase K (100 mg/ml) at 62°C for 2 h 
with shaking to elute and reverse cross-link DNA. The complex was heated at 95°C for 
10 min to inactivate proteinase K. The supernatant was collected after separation by 
magnetic particle concentrator. Two hundred µl phenol/chloroform/isoamylalchohol 
were added to each sample and vortexed for 1 min. The supernatant was then transferred 
                                                                                          MATERIALS AND METHODS 
- 54 - 
 
into a new Eppendorf tube after centrifugation at 16060 × g at 4°C for 15 min. Next, 25 
µl sodium acetate, 1 ml of 100% ethanol and 3 µl glycogen (20 mg/ml) were added and 
kept at -80°C for 1 h to precipitate DNA. The DNA pellet was washed once with 70% 
ethanol and subsequently dried at 37°C for 15 min. DNA was dissolved by adding 40 µl 
of water. The precipitated DNA was analyzed by iCycler real-time PCR system using 
the iQSYBR Green Supermix. The PCR conditions were 8 min at 95°C and then 20 sec 
at 95°C, 30 sec at 59.6°C, 30 sec at 72°C for 45 cycles. 2% of input was compared to the 
IP sample and the values from the IgG control were subtracted as background. The 
primers were purchased from MWG-Biotech (Ebersberg, Germany). Primers for BIM 
promoter region were as follows:  
Forward: 5’-GGTGATGAAGAGTCCCGCTT-3’  
Reverse: 5’-GGTGCAAGGATGGGTACTGT-3’  
 
2.2.10 Bisulfite sequencing 
 
   For bisulfite sequencing Sertoli cells were infected with UPEC for 4 and 6 h, 
respectively. DNA was extracted using DNeasy Blood & Tissue Kit (Qiagen, Venlo, 
The Netherlands) according to the manufacturer’s instruction. Briefly, after infection 
Sertoli cells were collected in 1.5 ml microcentrifuge tubes and washed two times with 
PBS by centrifugation at 300 × g at 4°C to get rid of residual medium. After 
centrifugation, the supernants were decanted and pellets were resuspended in 200 µl 
PBS. Next, 20 µl proteinase K and 200 µl buffer AL were mixed thoroughly with Sertoli 
cell suspension and incubated at 59.6°C for 10 min. Each mixture was transferred into a 
spin column (with the collection tube) and centrifuged at 6,000 × g for 1 min. The flow-
through was discarded and the spin column was inserted into a new collection tube. AW 
1 (500 µl) was added to the spin column to wash the column membrane by 
centrifugation at 6,000 × g for 1 min. The collection tube was replaced and AW 2 (500 
µl) was added in a new collection tube and the spin column was centrifuged for 3 min at 
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20000 × g. The spin column was placed in a new 1.5 ml collection tube, 40-60 µl buffer 
AE were added directly to the column membrane. After incubation for 1 min at room 
temperature, the DNA was eluted by centrifugation at 16,060 × g for 1 min. DNA 
concentration of each sample was measured by NanoDrop. All the above steps were 
performed at room temperature if not indicated differently. A maximum of 2 µg Sertoli 
cell DNA or genomic rat DNA was used for bisulfite conversion with EpiTect Fast 
Bisulfite Conversion Kit (Qiagen) according to the manufacturer s´ guide. Sodium 
bisulfite converts unmethylated cytosines to uracils, while methylated cytosines are 
unaffected. Converted DNA was amplified using different primer pairs (as follows) in 
standard PCR. The primers bind both methylated and unmethylated templates. PCR was 
performed in a 50 µl reaction volume containing 250 ng of bisulfite converted DNA, 
PCR buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.66 µM of each primer and 0.5 µl 
of GoTaq polymerase (Promega, Mannheim, Germany). After an initial 95°C step for 2 
min, DNA was amplified in 40-45 cycles for 30 sec each at 95°C, appropriate annealing 
temperature (indicated in Table 6) and 72°C followed by final extension at 72°C for 10 
min. Each PCR-product underwent preparative agarose gel electrophoresis. Expected 
signals were excised from the gel and purified using GeneJET Gel Extraction Kit 
(Thermo Fisher Scientific, Waltham, USA) according to the manufacturer’s protocol. As 
a positive control genomic testicular rat DNA was methylated in vitro using SssI 
methylase (New England Biolabs, Hertfordshire, UK) according to the manufacturer’s 
guidelines and cleaned up using GeneJET PCR Purification Kit (Thermo Fisher 
Scientific). The eluated DNA was sequenced by Seqlab, Sequence Laboratories, 
Göttingen using corresponding forward primers. Sequencing results were analyzed using 
Chromas Lite 2.1.1, a free software tool downloadable from http://technelysium.com.au/. 
The comparison of peaks in the pyrogram for cytosine and thymine-signals within 
expected CpGs gives an indication of methylation status for each CpG within tested 
sequence. 
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Primer 
 
Primer sequence (5´-3) 
Annealing 
temperature 
(°C) 
Amplified 
area 
(bp from 
TSS) 
 
Product size 
(bp) 
CpG1-
fw 
5’TTGTTTTAATTTTG
TGAGGAAA3’ 
 
56,5 
 
-2392/-2081 
 
311 
CpG1-
rv 
5’CCAAATCAAAAC
ACAAATAAAA3’ 
CpG2-
fw 
5’AGTTTGGGGTTTT
GTTGTGTTA3’ 
 
62 
 
-1317/-990 
 
327 
CpG2-
rv 
5’AAAATCCCCTAAC
CCTCCTAAA3’ 
CpG3-
A-fw 
5’AATTTAGTTTTTTT
GGTTTGGG3’ 
 
60 
 
-459/-12 
 
         447 
CpG3-
A-rv 
5’ACCCCAACCACTC
TACTCTTAC3’ 
CpG3-
B-fw 
5’TAAAGGGATGTTT
TTGAAGGTT-’ 
 
58,7 
 
+1891/+2281 
 
390 
CpG3-
B-rv 
5’TTCCTTCAAAACA
AACTTAAATCA3’ 
Table 6: Primer pairs for bisulfite sequencing. 
fw = Forward, rv = reverse, bp = base pairs, TSS = transcription start site. 
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3 RESULTS 
3.1 UPEC suppress the AKT survival signaling pathway in 
an experimental epididymo-orchitis model 
 
   Previous studies from our group have demonstrated that necrosis constitutes the 
predominant cell death pathway in UPEC infected rat testis (Lu et al., 2013). To 
determine whether UPEC impede the host’s AKT survival signaling pathway and 
actively alter the ability of infected cells for cellular survival, Western blot analysis 
was performed in testicular homogenates collected 7 d post UPEC infection in the vas 
deferens. As compared to sham control, levels of phosphorylated AKT decreased or 
were not detectable in UPEC infected testis (Figure 6A). In agreement, 
immunofluorescence analysis of phosphorylated AKT in cryosections of infected 
testis revealed a strong staining of cells in the seminiferous epithelium and testicular 
interstitial space, whilst control testis sections showed only faint labeling (Figure 6B). 
 
      
     Figure 6: UPEC inactivate AKT survival signaling pathway in vivo. (A) Testicular homogenates 
of sham control (Ctrl) and UPEC treated groups were separated by SDS-PAGE (n=3, 50 µg) and 
immunoblots were probed with p-AKT (Ser 473), and β-actin as loading control. (B) Cryosections of 
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sham control testis (Crtl) and testis collected 7 d after UPEC infection were probed with p-AKT (Ser 
473). Primary antibodies were visualized with Cy3-labeled secondary antibodies and nuclei were 
counterstained with DAPI. Micrographs were taken using an Axioplan 2 fluorescence microscope (Carl 
Zeiss, ×20 objective lens). Scale bars = 50 μm. 
 
3.2 UPEC activate FOXO transcription factors following 
AKT dephosphorylation in the experimental epididymo-
orchitis model 
 
   Dephosphorylation of AKT leads to activation of FOXOs. Hence, the 
phosphorylation status of FOXO1 (Thr 24) and FOXO3 (Thr 32) was determined in 
UPEC infected testes. Similar to AKT, phosphorylation of FOXO1 and FOXO3 was 
decreased or absent in UPEC infected testis as determined by Western blot (Figure 
7A). Immunofluorescence of FOXO1 was very weak in sham control testis, whilst 
prominent labeling of FOXO1 was evident in meiotic germ cells, round spermatids 
and likely Sertoli cells of UPEC infected testis. In infected testis, fluorescence 
intensity increased and was visible in the nuclei of cells located at the base of the 
seminiferous epithelium with labeling in the peritubular cells mostly lost (Figure 7B, 
C). Taken together, these results indicate that UPEC infection leads to the suppression 
of AKT survival signaling pathway and consequently activation of FOXO 
transcription factors in UPEC infected testis. 
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     Figure 7: FOXOs were activated following AKT inhibition in vivo. (A) Testis homogenates of 
sham control (Ctrl) and UPEC treated groups were separated by SDS-PAGE (n=3, 50 µg) and 
immunoblots were probed with p-FOXO1 (Thr 24), p-FOXO3 (Thr 32) and ß-actin as loading control. 
(B, C) Cryosections of sham control testis (Crtl) and testis collected 7 d after UPEC infection were 
probed with (B) FOXO1 and (C) FOXO3 antibodies. Primary antibodies were visualized with Cy3-
labeled secondary antibodies and nuclei were counterstained with DAPI. Micrographs were taken using 
an Axioplan 2 fluorescence microscope (Carl Zeiss, ×20 objective lens) and representative figures are 
shown. In control group, the arrowheads indicate cells with FOXO1 or FOXO3 cytoplasmic location; 
whilst the arrowheads indicate cells with positive nuclear staining of FOXO1 or FOXO3 in UPEC 
treated group. Scale bars= 50 μm. 
 
3.3 UPEC virulence factor α-hemolysin suppresses the AKT 
survival signaling pathway in Sertoli cells 
 
   The fact that in our previous study substantial necrotic changes were seen in Sertoli 
cells in UPEC infected testis (Lu et al., 2013) and FOXO immunofluorescence was 
visible predominantly in the nuclei of Sertoli cells in this tissue (Figure 8A, B), 
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prompted to examine whether the UPEC pore forming virulence factor α-hemolysin is 
involved in Sertoli cell death by attenuation of the AKT survival pathway. Therefore, 
isolated rat Sertoli cells were infected in vitro with UPEC strains expressing α-
hemolysin (UPEC 536) and a mutant with deletion of both α-hemolysin genes in 
UPEC 536 (HDM = hemolysin double mutant).  
 
   UPEC completely abrogated AKT phosphorylation (Ser 473) after 4 h post 
infection, whilst infection with HDM showed no change after 4 h and a marked 
increase of AKT phosphorylation 6 h post infection (Figure 9A, B). To verify the role 
of α-hemolysin in AKT dephosphorylation, Sertoli cells were challenged with UPEC 
in calcium free medium with the phosphorylation status of AKT remaining unchanged 
(Figure 9 C).  
 
      
     Figure 8: Localization of FOXO1 and FOXO3 in Sertoli cells using an in vivo acute bacterial 
orchitis model. UPEC infected testicular cryosections were probed with FOXO1 (A) and (B) FOXO3 
antibodies followed by detection with Cy3-labeled secondary antibody. Nuclei were counterstained 
with DAPI. Sertoli cells were identified according to nuclear morphology and localization within the 
seminiferous epithelium. Images were taken using an Axioplan 2 fluorescence microscope (Carl Zeiss, 
×40 objective lens) and representative figures are shown. Arrowheads indicate Sertoli cells with 
positive nuclear FOXO1 or FOXO3 staining. Scale bars =20 μm. 
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     Figure 9: α-hemolysin is the responsible UPEC virulence factor for inactivation of the AKT 
signaling pathway in isolated Sertoli cells. (A) Sertoli cells were treated with UPEC MOI: 0.01 for 
the indicated time periods. Protein extracts (20 µg) were separated by SDS-PAGE and immunoblots 
were probed with p-AKT (Ser 473) and total AKT. (B) Sertoli cells were treated with HDM MOI: 0.01 
for the indicated time points. Extracts of whole cell lysates (20 µg) were immunoblotted for p-AKT 
(Ser 473) and total AKT. (C) AKT dephosphorylation caused by UPEC infection is calcium dependent. 
Sertoli cells were incubated in calcium free medium 1 h prior infection with UPEC (MOI: 0.01) for the 
indicated time periods. Total cell lysates were subjected to Western blot analysis using antibodies 
against p-AKT (Ser 473) and total AKT. (A-C) Detection of β-actin served as loading control. Data are 
representative of three independent experiments. 
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3.4 UPEC virulence factor α-hemolysin suppresses the AKT 
survival signaling pathway in both peritubular myoid cells 
and 5637 cells 
 
   In order to determine whether AKT dephosphorylation represents a cell specific 
event or a more general phenomenon, testicular peritubular myoid cells and a 
uroepithelial cell line (5637) were treated with UPEC. Both cell types serve as models 
for UPEC target cells organs typically reached in infection (urinary tract, testis). In 
both cases UPEC infection ablated AKT activation, indicating a more general 
phenomenon (Figure 10A, B). 
 
      
     Figure 10: UPEC infection inhibits the AKT signaling pathway in isolated peritubular 
myeloid cells and 5637 cells. (A) Peritubular myeloid cells were treated with UPEC (MOI: 0.01) for 
the indicated time periods. Protein extracts (20 µg) were separated by SDS-PAGE and immunoblots 
were probed with p-AKT (Ser 473) and total AKT. (B) 5637 cells were treated with UPEC (MOI: 1) 
for the indicated time periods. Protein extracts were separated by SDS-PAGE and immunoblots were 
probed with antibodies against p-AKT (Ser 473) and total AKT. AKT detection served as loading 
control. 
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3.5 Dephosphorylation of FOXOs following AKT inhibition 
in Sertoli cells after UPEC infection 
 
   In order to investigate if FOXOs are also activated in testicular Sertoli cells 
following AKT suppression similar to the observation in testis, FOXO1 and FOXO3 
levels were examined by Western blot analysis. Immunoblot data revealed that 
phosphorylation of FOXO1 (Thr 24), FOXO1 (Ser 253), FOXO3 (Thr 32), and 
FOXO3 (Ser 256) were barely detectable in isolated Sertoli cells 4 h after UPEC 
infection (Figure 11A, B). Analysis of the phosphorylation status of FOXO4 (Thr 28) 
demonstrated a similar result (Figure 12C). 
      
     Figure 11: UPEC induce dephosphorylation of FOXO family proteins in isolated Sertoli cells. 
(A, B, C) Sertoli cells were challenged with UPEC for the indicated time periods. Extracts of whole 
cell lysates (20 µg) were subjected to Western blot analysis using antibodies against p-FOXO1 (Thr 
24), p-FOXO1 (Thr 256) FOXO1, p-FOXO3 (Thr 32), p-FOXO3 (Thr 253), FOXO3, p-FOXO4 (Thr 
28), and FOXO4. β-actin served as loading control. 
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3.6 Nuclear accumulation of FOXOs after UPEC treatment 
in Sertoli cells 
 
   In order to investigate the subcellular localization of FOXOs following 
dephosphorylation of AKT dependent lysine or serine sites, we have performed 
immunofluorescence analysis. As shown in Figure 12, FOXO1, FOXO3, and FOXO4 
accumulated in nuclei of Sertoli cells 4 h after exposure to UPEC, indicating that they 
are transcriptionally active. 
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     Figure 12: UPEC induce nuclear accumulation of FOXO family proteins. UPEC infection 
causes (A) FOXO1 (B) FOXO3 and (C) FOXO4 nuclear accumulation in Sertoli cells. Cells were 
incubated with UPEC or RPMI medium alone as control (Crtl) for 4 h. Immunofluorescence staining 
was performed for FOXO1, FOXO3 and FOXO4, and visualized using Cy3 labeled secondary 
antibodies. Nuclei were counterstained with Cy5-conjugated TO-PRO-3 dye. Images were visualized 
using TCS SP2 confocal laser-scanning microscope (Leica Microsystems, Germany). The 
representative images are shown. 
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3.7 The DNA binding activity of FOXO1 increases following 
UPEC treatment in Sertoli cells 
 
   To verify if FOXOs are indeed transcriptionally active following dephosphorylation 
and nuclear accumulation, the DNA binding activity was measured. FOXO1 DNA 
binding activity was significantly increased 4 h post UPEC infection in Sertoli cells, 
compared to control and 2 h UPEC infection. 
 
      
     Figure 13: UPEC increase FOXO1 DNA binding activity. Sertoli cells were incubated with 
UPEC (MOI: 0.01) for the indicated time points or medium alone as control (Ctrl). DNA binding 
activity of FOXO1 was measured in nuclear extracts using the Trans-AM FKHR kit. Data are shown as 
mean ± SD of three independent experiments. Statistical analysis was performed using one-way 
ANOVA to determine the significant difference. *p<0.05.  
 
3.8 FOXO signaling pathway is not activated by HDM 
infection 
 
   Next, we sought to determine whether the UPEC virulence factor HlyA is 
responsible for activation of FOXOs. Therefore, isolated rat Sertoli cell were 
incubated with HDM. Treatment with HDM failed to inactivate AKT signaling, 
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instead markedly increased the phosphorylation of AKT 6 h after infection. 
Consequently, an increase of phosphorylation of FOXO1 (Thr 24) and FOXO4 (Thr 
28) was observed 6 h post HDM infection. Changes in the phosphorylation status of 
other AKT dependent sites including FOXO1 serine 256, FOXO3 threonine 32 and 
serine 253 were not visible. Together these results strongly propose a role for the 
UPEC virulence factor α-hemolysin in activation of FOXO transcription factors in 
Sertoli cells. 
 
      
     Figure 14: FOXOs remain phosphorylated after HDM infection. Sertoli cells were challenged 
with HDM (MOI: 0.01) for the indicated time periods. Whole cell lysates (20 µg) were subjected to 
Western blot analysis using antibodies against p-FOXO1 (Thr 24), p-FOXO1 (Ser 256), FOXO1, p-
FOXO3 (Thr 32), p-FOXO3 (Ser 253), FOXO3, p-FOXO4 (Thr 28) and FOXO4. β-actin was probed 
to ensure equal protein loading.  
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3.9 SOD2 and catalase are not upregulated after UPEC 
treatment 
 
   FOXOs accumulated in the nucleus can bind to promoters or enhancers to regulate 
expression of genes involved in apoptosis, ROS detoxification, DNA repair and cell 
cycle arrest. It recently has been reported that Porphyromonas gingivalis, a prominent 
periodontal and emerging systemic pathogen, could activate FOXO transcription 
factors to control oxidative stress responses by upregulation of superoxide dismutase 
2 (SOD2) and catalase (Wang et al., 2015). The upregulation of SOD2 and catalase by 
the FOXO family could detoxify ROS as a cell survival strategy (Kops et al., 2002; 
Storz, 2011). Therefore, as the next step, we investigated the expression levels of 
these enzymes by qRT-PCR and Western blot analysis. Surprisingly, protein and 
mRNA expression levels of FOXO target gene SOD2 and catalase were not regulated 
by UPEC infection at any of the investigated time points.  
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     Figure 15: FOXO dependent genes SOD2 and catalase are not upregulated after UPEC 
treatment. SOD2 (A, B) and catalase (C, D) are not upregulated both at protein and mRNA level. 
Sertoli cells were infected with UPEC (MOI: 0.01) for the indicated time periods. Whole cell lysates 
(20 µg) were immunoblotted for SOD2, catalase, and β-actin. β-actin used as loading control. The total 
RNA was isolated from cells treated with UPEC (MOI: 0.01) at the indicated time periods. The 
amounts of SOD2 and catalase mRNA were quantified by qRT-PCR. Results were normalized to 
expression levels of β-2-microglobulin. All data are shown as mean ± SD of at least three independent 
experiments. Statistical analysis was performed using one-way ANOVA to determine the significance 
of the differences. Differences were considered to be significant when p<0.05.  
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3.10 FOXO dependent genes involved in cell cycle arrest and 
DNA repair are not regulated after UPEC treatment 
 
   It has also been demonstrated that FOXOs are associated with cell cycle arrest by 
regulating a set of genes involved in cell cycle progression. However, mediators of 
cell cycle arrest such as p27kip1, p15INK4B, cyclin D1 and cyclin D3 were not 
regulated in Sertoli cells after UPEC treatment as demonstrated by Western blot 
analysis (Figure 16A). Similarly, another FOXO target gene Gadd45α, involved in 
DNA repair, also did not show any significant change at the mRNA level (Figure 
16B). 
 
      
     Figure 16: FOXO target genes involved in cell cycle arrest and DNA repair were not regulated 
at the expression level. (A) Sertoli cells were infected with UPEC (MOI: 0.01) for the indicated time 
periods. Extracts of whole cell lysates were separated by SDS-PAGE and immunoblots were probed 
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with antibodies directed against p27Kip1, p15INK4B, cyclin D1 and cyclin D3. β-actin detection 
served as loading control. (B) Sertoli cells were infected with UPEC (MOI: 0.01) for the indicated time 
periods. mRNA levels of Gadd45α were assessed by qRT-PCR. Results were normalized to expression 
levels of β-2-microglobulin. Presented data are shown as mean ± SD of at least three independent 
experiments. One-way ANOVA was performed to determine the significance of the differences. 
Differences were considered to be significant when p<0.05. 
 
3.11 Expression of the pro-apoptotic gene BIM is not 
increased after UPEC treatment 
 
   We hypothesized that FOXOs could induce BIM to induce apoptosis in Sertoli cells. 
Yet, Western blot data did not show any significant change of BIM at the protein level 
(Figure 17A). However, the mRNA level somewhat reduced, albeit not statistically 
significant (Figure 17B). 
 
      
     Figure 17: Expression of the pro-apoptotic gene BIM was not regulated after UPEC treatment. 
(A, B) BIM is not upregulated both at the protein and mRNA levels. Sertoli cells were infected with 
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UPEC MOI: 0.01 at the indicated time periods. Protein extracts were immunoblotted for BIM and β-
actin. β-actin was used to ensure equal protein loading. The mRNA level of BIM was assessed by qRT-
PCR. Results were normalized to expression levels of β-2-microglobulin. Presented data are shown as 
mean ± SD of at least three independent experiments. Statistical analysis was performed using one-way 
ANOVA to determine the significance of the differences. Differences were considered to be significant 
when p<0.05. 
 
3.12 FOXOs were activated by the PI3K inhibitor 
 
   In spite of the nuclear translocation of FOXO and enhanced DNA binding activity 
following UPEC infection, no significant increase in the expression of FOXO target 
genes was evident. Hence, it was investigated determine whether this phenomenon 
was specific to the investigated cell type or can be attributed to the pathogen 
independent of the infected cell type. Therefore, Sertoli cells were treated with the 
PI3-kinase/AKT inhibitor LY249002 and subsequently analyzed for AKT 
phosphorylation. As shown in Figure 18A, levels of phosphorylated AKT were 
prominent at 0 h, but were undetectable at 16 and 24 h after treatment. Concomitantly, 
FOXO1 and FOXO3 were found to be dephosphorylated (Figure 18B). 
 
      
     Figure 18: FOXOs are activated following AKT inhibition by PI3K inhibitor in Sertoli cells. 
(A, B) Sertoli cells were treated with the PI3K inhibitor LY249002 (50µM) at the indicated time 
points. Protein extracts were subjected for Western blot analysis using antibodies against p-AKT (Ser 
473), AKT, β-actin, p-FOXO1 (Thr 24), p-FOXO3 (Thr 32), FOXO1, FOXO3 and β-actin. β-actin was 
probed to ensure equal protein loading.  
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3.13 BIM is upregulated by the PI3K inhibitor, but 
suppressed by UPEC infection 
 
   Of note, the protein levels of the FOXO target genes SOD2, Catalase, and p27KIP1 
remained unchanged as examined by Western blot analysis (Figure 19A). In contrast, 
protein and mRNA expression levels of BIM were significantly increased 16 and 24 h 
after LY249002 treatment (Figure 19B, C). To investigate this further, Sertoli cells 
were treated with LY249002 for 12 h followed by treatment with UPEC for 4 h. 
Remarkably, UPEC significantly suppressed LY249002-induced expression of BIM 
(Figure 19C). Because Sertoli cells are resistant to apoptosis (unpublished data from 
Dr. Sudhanshu Bhushan), the uroepithelial cell line 5637 was challenged with 
LY249002 for 13 h followed by treatment with UPEC for 3 h. Intriguingly, UPEC 
significantly suppressed LY249002 induced apoptosis as shown in Figure 19D. 
 
      
     Figure 19: BIM is unregulated by the PI3K inhibitor in Sertoli cells. (A, B) Sertoli cells were 
treated with the PI3K inhibitor LY249002 (50 µM) at the indicated time points. Protein extracts were 
subjected to Western blot analysis using antibodies against SOD2, p27kip1, catalase and BIM. β-actin 
was probed to ensure equal protein loading. (C) Sertoli cells were treated with LY249002 (50 µM) 12 h 
prior to UPEC infection for another 4 h (MOI: 0.01). The amount of BIM mRNA was quantified by 
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qRT-PCR. Results were normalized to expression levels of β-2-microglobulin. Data are shown as mean 
± SD. Presented data are representative for three independent experiments. Statistical analysis was 
performed using one-way ANOVA to determine the significance of the differences. *p<0.05. (D) 5637 
cells were pre-treated with LY249002 (50 µM) for 13 h followed by co-incubation with UPEC (MOI:1) 
for another 3 h. Cell lysates (20 µg) were subjected to Western blot analysis using antibodies against 
cleaved-caspase 3 and β-actin. β-actin served as loading control. 
 
3.14 The status of CpG islands within the promoter region of 
BIM remains unmethylated after UPEC treatment 
 
   It has been reported that the CpG islands within the promoter region of BIM can be 
methylated in order to silence BIM expression as a survival strategy utilized by 
viruses or cancer cells(Bachmann et al., 2010; Paschos et al., 2009; Piazza et al., 
2013). Similarly, Tolg et al have shown that UPEC infection provokes down-
regulation of CDKN2A (p16INK4A) by inducing CpG island methylation (Tolg et al., 
2011). As the expression level of BIM mRNA was down-regulated after UPEC 
exposure, the methylation status was analyzed at various sites at the BIM promoter 
region as a possible mechanism using bisulphite sequencing (Figure 20A). The 
performance of all used primer pairs was validated prior testing. A representative 
analysis of CpG1 primers is shown (Figure 20B). The methylation profile at the BIM 
promoter region in Sertoli cells did not change after UPEC infection (Figure 20C). As 
a positive control in vitro methylated rat genomic DNA was used. 
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     Figure 20: Infection of Sertoli cells with UPEC has no effect on the methylation status of the 
BIM-promoter. Sertoli cells were treated with UPEC for 4 and 6 h (MOI: 0.01). After harvesting the 
cells, genomic DNA was isolated following bisulfite conversion of non-methylated CpGs. Four areas of 
the BIM promoter in those converted samples were analyzed by sequencing. (A) A schematic overview 
of the CpG-Islands (defined by http://cpgislands.usc.edu/) within the BIM promoter relative to the 
transcription start site (TSS) is shown. Amplified and analyzed regions are indicated as CpG1, CpG2, 
CpG3A and CpG3B. (B) The performance of all used primer pairs was verified. A representative 
analysis of CpG1-fw + CpG1-rv is shown. The expected 311 bp product is only visible for bisulfite 
converted DNA (BC). The “no template control” (NTC) and the “non bisulfite control” (NBC) do not 
show this product. (C) Methylation status and distance from TSS for tested CpGs is shown for different 
treatments. Filled (black) circles correspond to methylated CpGs, unfilled (white) circles correspond to 
unmethylated CpGs. Experiments and analysis were performed 3 times. To show method´s competence 
of detecting methylated CpGs (positive control) untreated testicular rat DNA was analyzed and 
compared to in vitro methylated testicular rat DNA. 
 
3.15 UPEC, but not HDM deacetylate both histone 3 and 4 
 
   Next, we evaluated the changes of global histone acetylation by Western blotting. 
Of note, UPEC infection completely abrogated global histone 3 (H3) and histone (H4) 
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acetylation in Sertoli cell extracts 4 h post-treatment. In contrast, challenge with HDM 
did not cause any changes in the global acetylation status of histone 3 and histone 4 
(Figure 21A, B). 
 
      
     Figure 21: Infection with UPEC, but not HDM caused global deacetylation of both histone 3 
and 4. (A, B). Sertoli cells were treated with UPEC or HDM (MOI: 0.01) for the indicated time 
periods. Protein extracts (20 µg) were separated by SDS-PAGE and immunoblots were probed with 
antibodies against acetylated histone 3 and acetylated histone 4. Detection of β-actin served as loading 
control. 
 
3.16 Acetylation of histone 3 and 4 decreased in UPEC 
infected testis 
 
   The acetylation status of histone 3 and 4 were further investigated in UPEC elicited 
orchitis. The immunofluorescence data using acetylated histone 3 and histone 4 
antibodies indicated that a decrease in UPEC infected testis in comparison to mock 
infected testis. These results confirmed that UPEC can deacetylate histone 3 and 
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histone 4 in vitro as well as in vivo. 
 
      
     Figure 22: UPEC infection caused a global decrease of histone 3 and histone 4 acetylation. (A, 
B) Cryosections of sham control testis (Crtl) and testis collected 7 d after UPEC infection were probed 
with antibodies direct against acetylated histone 3 and acetylated histone 4. Primary antibodies were 
visualized with Cy3-labeled secondary antibodies and nuclei were counterstained with DAPI. 
Micrographs were taken using an Axioplan 2 fluorescence microscope (Carl Zeiss, ×20 objective lens). 
The representative images are shown. Scale bars= 50 μm. 
 
3.17 The decrease of histone 4 acetylation at the BIM 
promoter region is associated with a suppression of BIM 
expression after UPEC infection 
 
   In order to unravel the underlying mechanism how UPEC suppress the expression 
of BIM – in spite of activated FOXOs -ChIP analysis was performed using acetylated 
histone 3 and histone 4 antibodies. The acetylation status of histone 4 was decreased 
after UPEC treatment in comparison with control at the BIM promoter region (Figure 
23A). However, the acetylation of histone 3 did not change significantly (Figure 23B). 
Taken together, UPEC suppress BIM transcription by decreasing histone 4 acetylation 
at its promoter region. 
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     Figure 23: UPEC suppress BIM expression by deacetylation of histone 4 at the promoter 
region. (A, B) UPEC challenge caused deacetylation of histone 4 at the BIM promoter region. Sertoli 
cells were treated with UPEC (MOI: 0.01) for 4 h and then subjected to ChIP assay. 
Immunoprecipitated DNA associated with acetylated histone 3 and 4 were assayed by qPCR. The 
graphs represent percentage changes of fold enrichment relative to input chromatin for the UPEC 
treated group in comparison to the control group. Data are shown as mean ± SD. Presented data are 
representative for three independent experiments. Statistical analysis was performed using Student’s t-
test to determine the significance of the differences. *p<0.05. 
 
3.18 Acetate partially rescues histone 3 and 4 deacetylation 
after UPEC infection  
 
   In the nuclei of mammalian, citrate is catalyzed to acetyl coenzyme A to provide 
acetyl groups for histone acetylation by an ATP-dependent-lyase (ACLY) (Choudhary 
et al., 2014). The activity of ACLY is controlled by AKT-dependent phosphorylation. 
As shown above activation of AKT was attenuated by UPEC in infected Sertoli cells. 
Therefore, it was hypothesized that attenuation of AKT will results in 
dephosphorylation of ACLY. Surprisingly, the expression of phosphorylated ACLY 
was not detectable in Sertoli cells. In a next step, Sertoli cells were treated with UPEC 
and sodium acetate (a metabolite that can be catalyzed to acetyl coenzyme A 
independent of AKT activity). Western blot results showed that the deacetylation of 
histone 3 and histone 4 were rescued 4 h and 6 h post UPEC infection by adding 
acetate (Figure 24). Taken together, these results indicate that UPEC can decrease 
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acetyl coenzyme A level to cause deacetylation of histone 3 and histone 4. 
      
     Figure 24: Supplement of acetate rescued histone 3 and histone 4 deacetylation after UPEC 
infection. Sertoli cells were treated with UPEC (MOI: 0.01) and sodium acetate (5 mM) for the 
indicated time periods. Protein extracts (20 µg) were prepared in SDS lysis buffer and equal amounts 
of protein were separated by electrophoresis on SDS-PAGE. Immunoblots were probed with antibodies 
recognizing acetylated histone 3, acetylated histone 4 and β-actin. β-actin detection served as general 
loading control. 
 
3.19 UPEC inhibit ACLY activity thus inducing 
deacetylation of histone 3 and 4 
 
   In order to test the hypothesis that suppression of AKT/ACLY signaling pathways 
by UPEC can result in histone 3 and histone 4 deacetylation, uroepithelial cells (5637) 
were treated with UPEC. The immunoblotting data demonstrated that the 
phosphorylation of ACLY was completely abrogated 2 h after UPEC infection (Figure 
25A). Similar to Sertoli cells, addition of acetate rescued histone 3 and histone 4 
deacetylation in 5637 cells after UPEC infection (Figure 25B). 
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     Figure 25: UPEC inhibit ACLY activity and acetylation of histone 3 and histone 4 partially 
maintained by adding with acetate. (A) Uroepithelia cells (5637) were treated with UPEC (MOI: 1) 
for the indicated time periods. Protein extracts (20 µg) were separated by SDS-PAGE. Immunoblots 
were probed with antibodies direct against p-ACLY (Ser 455) and ACLY. Detection of ACLY served 
as loading control. (B) 5637 cells were treated with UPEC MOI: 1 with/out sodium acetate (5mM) for 
the indicated time periods. Protein extracts (20µg) were subjected to Western blot analysis using 
antibodies against acetylated histone 3 and acetylated histone 4. β-actin detection was probed to ensure 
equal protein loading. 
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4 DISCUSSION 
 
   Death of host cells is a well established and obvious consequence of host-pathogen 
interaction during infection. Emerging data demonstrate that cell death caused by 
microbial infection often does not constitute an ancillary phenomenon, but is a 
controlled and adjustable process by the host to eliminate pathogens, clear damaged 
cells, and limit the spread and magnitude of inflammation. In this regard, apoptosis is 
an immunologically silent death mode, whereas necrosis represents an inflammatory 
mode of death (Lamkanfi and Dixit, 2010). During evolution, pathogens have 
enhanced their ability to persist by developing multiple strategies to manipulate the 
cell death pathways, primarily to propagate inside the host cell and to avoid host 
innate immune responses. In this study, it has been demonstrated that the UPEC 
virulence factor HlyA could manipulate host cell death pathways to facilitate 
pathogen survival and dissemination. UPEC can suppress the expression of the pro-
apoptotic FOXO target gene BIM in isolated rat Sertoli cells, although the 
AKT/FOXO signaling pathway usually leading to BIM synthesis is activated at the 
same time. Moreover, it has also been confirmed that UPEC-mediated histone 
deacetylation is associated with BIM suppression, a molecular switch which drives 
Sertoli cells in necrosis, but prevents apoptosis. Preventing programmed cell death in 
Sertoli cells as obligatory “nurse cells” for the developing germ cells is essential to 
maintain or recover spermatogenic potential during or after infectious episodes. This 
gains particular importance as one Sertoli cell supports a large number of adjacent 
germ cells. 
 
4.1 UPEC inhibit the AKT signaling pathway in vivo and in 
vitro 
 
   AKT is comprised of an N-terminal pleckstrin homology (PH) domain, a kinase 
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domain and a C-terminal regulatory tail, and is activated by many stimuli such as 
growth factors and cytokines (Hers et al., 2011; Staal, 1987). Following the 
stimulation by growth factors, the lipid enzyme PI3 kinase signaling pathway is 
activated, which further causes the generation of phosphatidylinositol-3, 4, 5-
phosphate (PIP3) and recruits AKT as well as 3-phosphoinositide-dependent protein 
kinase 1 (PDK1) to the cell membrane. PIP3 can elicit a conformational change in 
AKT via binding to the PH domain, consequently enabling the co-recruited PDK1 to 
access the activation loop of AKT and phosphorylate threonine 308 (Hers et al., 
2011). Activated AKT contributes to phosphorylation of a large number of 
downstream substrates including FOXOs and GSK3β, and is thereby involved in 
metabolism, growth, cell proliferation, and cell survival (Manning and Cantley, 2007). 
Data shown in this study demonstrate that UPEC can induce dephosphorylation of 
AKT serine 473 in isolated rat Sertoli cells 4 h post infection. Similar results are also 
observed in UPEC-infected rat testes. It has been shown that for maximal activity 
AKT needs the phosphorylation of serine 473 catalyzed by the mTOR complex 2 
(mTORC2) (Zhang et al., 2011). In contrast, the AKT signaling pathway is terminated 
or inhibited by dephosphorylation of threonine 308 or serine 473. Therefore, in the 
present study UPEC can abrogate the pro-survival AKT signaling pathway both in 
vitro (isolated rat Sertoli cells) and in vivo (UPEC-elicited rat epididymo-orchitis 
model). 
 
   It has been shown that pore formation on cell membranes caused by the UPEC 
virulence factor HlyA is required for AKT dephosphorylation (Wiles et al., 2008; 
Wiles and Mulvey, 2013). Besides HlyA from UPEC, other bacterial pore-forming 
toxins such as aerolysin from Aeromonas species and toxin from Staphylococcus 
aureus attenuate the AKT signaling pathway. Therefore, whether AKT is a general 
target for these pore-forming toxins or a coinciding ‘casualty’ of their toxic effects 
needs to be further investigated. In general, the pore formation on cell membranes 
could induce Ca2+ inﬂux and decrease cytosolic K+. However, neither chelation of 
intracellular Ca2+ nor supplementation of KCl into cell culture media (preventing K+ 
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leakage) could block UPEC-induced AKT dephosphorylation (Wiles et al., 2008). 
Therefore, the underlying molecular mechanism still remains elusive. In the same 
study, it has been shown that protein phosphatase 2A (PP2A) or protein phosphatase 1 
(PP1) inhibitors such as calyculin A, tautomycin or okadaic acid, could rescue HlyA-
mediated AKT dephosphorylation, suggesting a role for both PP2A and PP1 in this 
process (Wiles et al., 2008). In agreement with these studies, the results from our 
study confirmed that UPEC could suppress the AKT signaling pathway 4 h post 
infection in isolated Sertoli cells. In contast, infection with HDM (hemolysin double 
mutant) resulted in marked increase of AKT phosphorylation at 6 h post infection. 
Strikingly, AKT is constitutively active in mock-infected testis in comparison with 
UPEC-infected testis, indicating that the AKT signaling pathway plays an essential 
role in testis. As shown by Ostalaza and Goni, HlyA needs to bind to extracellular 
calcium in order to permeabilize cell membranes (Ostolaza and Goni, 1995). 
Similarly, we have demonstrated that HlyA requires extracellular calcium to 
inactivate the AKT signaling pathway. In addition, the ablation of the AKT signaling 
pathway is more of a general phenomenon, as it has been shown that AKT inhibition 
by UPEC is not restricted to Sertoli cells. The same phenomenon was also observed in 
peritubular myoid cells as well as uroepithelial cells (5637 cells). Taken together, 
these results indicate that the AKT survival signaling pathway was inhibited by UPEC 
infection. 
 
4.2 FOXOs are activated by UPEC infection 
 
   FOXOs function as transcription factor by binding to the conserved consensus core 
recognition motif TTGTTTAC to regulate specific gene expression programs 
(Furuyama et al., 2000; Obsil and Obsilova, 2011). FOXOs are negatively regulated 
by the AKT signaling pathway, whereas they could be activated through the JNK 
signaling pathway (Essers et al., 2004; Oh et al., 2005; van der Horst and Burgering, 
2007; Wang et al., 2005). The phosphorylation of FOXOs by AKT at conserved 
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threonine and serine sites leads to cytoplasm sequestration and further degradation 
(Tzivion et al., 2011). Growth factor withdrawal or other factors inhibit AKT 
signaling, which consequently results in FOXOs nuclear accumulation and activation. 
In the present study, it has been shown that the UPEC virulence factor HlyA inhibits 
the AKT signaling pathway, consequently activating downstream FOXO proteins. 
Moreover, in the UPEC-elicited rat orchitis model, activation of FOXO1 and FOXO3 
was documented by their dephosphorylation. The immunofluorescence data further 
confirmed that the expression of FOXO1 and FOXO3 was observed in the nuclei of 
testicular cells in the infected testis (Figure 7B, C). Additionally, in this experimental 
orchitis model, FOXOs are shown to be located in Sertoli cells, which are one of the 
most important somatic cell types in seminiferous tubules, playing an essential role in 
both supporting spermatogenesis and maintaining immune tolerance (Kaur et al., 
2014). In the mock-infected testis, both FOXO1 and FOXO3 are barely detectable, 
likely due to the constitutive activation of the AKT signaling pathway. This 
observation is similar to the study by Goertz and colleagues, in which they 
demonstrated that FOXO1 was only detectable in undifferentiated spermatogonia, but 
not in the Sertoli cells or any other somatic cells of the mouse testis, suggesting 
FOXO1 plays an essential role in maintenance of spermatogonial stem cells and 
initiation of spermatogenesis (Goertz et al., 2011). The same group further showed 
that FOXO1 was expressed in undifferentiated spermatogonia in other mammals 
including humans (Tarnawa et al., 2013). Similar to the UPEC-infected testis, FOXOs 
are also activated after UPEC infection in isolated Sertoli cells, which has been 
further confirmed by an increase in DNA binding activity (shown in Figure 13). In 
addition, HDM did not activate FOXOs due to the lack of the virulence factor HlyA. 
These results are in agreement with a previous study, which showed that following 
AKT inhibition by the UPEC virulence factor HlyA, the phosphorylation of FOXO1 
was decreased (Wiles et al., 2008).  
 
   Besides UPEC, other pathogens such as nontypeable H. inﬂuenzae (NTHi) activate 
FOXO transcription factors, e.g. in cultured human respiratory epithelial cells and in 
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alveolar and bronchial epithelial cells of infected mice in vivo. The increased 
expression of antimicrobial peptides and proinﬂammatory cytokines suggests that 
FOXOs transcription factors play an important role in innate immune responses 
against invading pathogens (Seiler et al., 2013). Moreover, the study by Becker et al. 
demonstrated a link between metabolism and FOXO driven innate immune response. 
In this regard, the activation of FOXO transcription factors by starvation using insulin 
signaling mutants or by applying small molecule inhibitors could induce antimicrobial 
peptides expression(Becker et al., 2010). Recently, a study by Lee and colleagues 
shed new light on understanding the mechanism of how the FOXO3 signaling 
pathway influences the outcomes of inflammatory and infectious disease. They 
identified a non-coding polymorphism in FOXO3 (rs12212067: T > G), at which the 
minor (G) allele is associated with a milder course of Crohn’s disease and rheumatoid 
arthritis, yet at the cost of an elevated risk of severe malaria. They further 
demonstrated that FOXO3 nuclear accumulation and activation was faster in the 
minor (G) allele homozygotes than in major (T) allele homozygotes following LPS 
stimulation in monocytes. FOXO3 could transcriptionally upregulate TGFβ 
expression, which reduces proinflammatory cytokine production including TNFα and 
increases anti-inflammatory cytokine production such as IL-10 (Lee et al., 2013). All 
these studies indicate the important role of FOXOs in inflammatory and infectious 
diseases. Similarly, in our study FOXOs were activated by UPEC infection indicating 
the involvement in this specific host immune response. Collectively, in the present 
study, AKT inhibition by the UPEC virulence factor HlyA leads to activation of 
FOXOs in vivo (experimental UPEC-elicited orchitis in rat) and in vitro (isolated rat 
Sertoli cells). 
 
   Upon activation, FOXOs accumulate in the nucleus and regulate the expression of 
an array of genes which play a critical role in cell survival, ROS detoxification as well 
as cell cycle arrest (Eijkelenboom and Burgering, 2013). The transcriptional output of 
FOXOs is highly context-dependent, a fact which has been documented in numerous 
reports (van der Vos and Coffer, 2011). In this regard, FOXOs could promote 
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oxidative stress resistance via transcriptional upregulation of two key ROS scavenger 
proteins, namely SOD2 and catalase (Kops et al., 2002; Nemoto and Finkel, 2002; 
Storz, 2011). ROS production is one of the early responses against bacterial infection 
to facilitate pathogen clearance and to activate signaling pathways related to 
inflammatary and immune responses (Spooner and Yilmaz, 2011). However, 
excessive production of ROS also leads to host cell apoptosis and tissue damage. 
Hence, ROS production needs to be stringently controlled during bacterial infection. 
UPEC infection could increase ROS production, considering that FOXOs play an 
important role in detoxifying ROS after UPEC infection. Therefore the first 
hypothesis was that FOXOs may induce catalase and SOD2 expression to control 
ROS production. Surprisingly, expression of catalase and SOD2 remains unchanged 
both at the mRNA and protein level in any of the investigated time periods. These 
results suggest that FOXOs may be involved in functions other than ROS 
detoxification. 
 
4.3 UPEC inhibit apoptosis by suppression of BIM 
expression  
 
   Archetypically, activation of FOXO triggers apoptosis in different cell types by 
increasing the levels of the pro-apoptotic protein BIM. It has been reported that 
FOXO3 upregulates BIM expression to induce neuron apoptosis in the context of 
growth factor deprivation (Gilley et al., 2003). In addition, Essafi and colleagues have 
shown that ST1571, a drug for chronic leukemia treatment, induces FOXO3 
activation and promotes apoptosis by upregulation of BIM. They further demonstrated 
that FOXO3 activated by ST1571 could bind to the FOXO binding site in the BIM 
promoter region to up-regulate BIM expression and trigger apoptosis, indicating 
FOXO3 is a key regulator for BIM expression and apoptosis (Essafi et al., 2005). 
Interestingly, the human T-cell leukemia virus type 1 (HTLV-1) virus encodes HTLV-
1 bZIP factor (HBZ), which could not only attenuate FOXO3 DNA binding, but also 
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sequestered the inactive form of FOXO3 in the nucleus. Consequently, the expression 
of the FOXO target gene BIM and FasL was inhibited. Therefore, HBZ-mediated 
BIM and FasL silencing is associated with apoptosis resistance of HTLV-1-infected T 
cells (Tanaka-Nakanishi et al., 2014). This study implicates that pathogen infection 
could manipulate host cell death pathways by affecting FOXO/BIM signaling. 
Similarly, in our study the data suggest that despite the activation of FOXOs 
following UPEC challenge, the mRNA expression level of BIM in Sertoli cells did not 
increase. UPEC-mediated BIM suppression was further confirmed by a co-incubation 
experiment of UPEC with the PI3K inhibitor LY294002. Here, UPEC significantly 
inhibited LY294002-induced mRNA expression of BIM. Of note, suppression of BIM 
expression resulted in inhibition of apoptosis by blocking caspase 3 activation (Figure 
19D). This mechanism is in agreement with other reports including E. coli pathovars, 
which suggest that bacterial pathogens hijack host cell apoptosis signaling by 
targeting the intrinsic mitochondrial pathway (Rudel et al., 2010). For instance, 
enteropathogenic Escherichia coli (EPEC) secrete NieH effectors interacting with the 
Bax inhibitor 1 to inhibit caspase 3 activation and apoptosis, whilst C. trachomatis 
inhibits caspase 3 activation by upregulating the expression of the anti-apoptotic 
genes cIAP1, cIAP2, XIAP and MCL1. As other examples, Yersinia pestis prevent 
host cell apoptosis via Pla (a member of the omptin family of bacterial outer 
membrane proteases) mediated Fas ligand (FasL) degradation and E. faecalis protects 
macrophages from apoptosis again by inhibiting caspase 3 activation as seen in our 
study (Caulfield et al., 2014; Hemrajani et al., 2010; Rajalingam et al., 2008; 
Rajalingam et al., 2006; Zou and Shankar, 2014). Taken together, in light of the 
literature our findings strongly propose that UPEC can hijack the host cell apoptosis 
pathway by suppressing BIM expression. In consequence, apoptosis is inhibited by 
attenuating caspase 3 activation. Additionally, the results also point towards a possible 
epigenetic regulation of BIM expression following UPEC infection. 
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4.4 UPEC epigenetically suppress the expression of the 
FOXO target gene BIM  
 
   In the recent past, a growing body of evidence indicates that bacteria and viruses 
can modulate the host gene expression pattern to escape the innate immune response 
of the host cells by epigenetic mechanisms such as DNA methylation, histone 
modifications, and chromatin complexes (Bierne et al., 2012; Gomez-Diaz et al., 
2012; Hamon and Cossart, 2008; Paschos and Allday, 2010).  
 
   DNA methylation is often associated with decreased gene expression, which could 
be used by pathogens to manipulate the host gene expression pattern. For instance, 
Helicobacter pylori infection could promote DNA methylation in the Trefoil factor 
(TFF) 2 promoter region and suppress TFF2 expression, consequently resulting in 
gastric tumor development (Peterson et al., 2010). In addition, UPEC infection could 
significantly increase the de novo DNA methyltransferases (DNMT) activity as well 
as DNMT1 RNA expression in uroepithelial cells. In consequence, UPEC suppress 
CDKN2A (p16INK4A) gene expression, involved in cell cycle arrest, by increasing 
DNA methylation in exon 1 region (Tolg et al., 2011). Recently, it has been 
demonstrated that a diversity of bacteria and viruses induce DNA methylation to 
manipulate host gene expression, such as Helicobacter pylori, Epstein-Barr virus, and 
Human papillomavirus E7 (Bierne et al., 2012; Paschos et al., 2009; Peterson et al., 
2010). Based on the observation that BIM expression is unchanged in spite of 
activated FOXOs, we investigated a possible epigenetic mechanism underlying this 
phenomenon. The epigenetic suppression of BIM expression has been documented in 
many tumor types, including leukemia, lymphoma, and lung cancer. The aberrant 
hypermethylation of a CpG island in the BIM promoter region has been demonstrated 
as a strategy to suppress BIM expression in cancer cells (Bachmann et al., 2010; 
Paschos et al., 2009; Piazza et al., 2013). It has also been demonstrated that Epstein-
Barr virus (EBV) could induce DNA methylation in the BIM promoter region which 
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is involved in suppression of BIM expression and enhance the infected cell survival 
(Paschos et al., 2009). As the first step, the DNA methylation profile of the BIM 
promoter region has been examined by bisulfide sequencing. However, DNA 
methylation in the BIM promoter region did not change following UPEC infection in 
Sertoli cells (Figure 20), excluding the possibility that DNA methylation plays a role 
in BIM suppression. 
 
   Apart from DNA methylation, bacteria such as Listeria monocytogenes, Clostridium 
perfringens and Streptococcus pneumonia and their secreted toxins modulate the host 
cell transcription profile through histone modifications (Hamon et al., 2007). Histone 
acetylation is an active histone marker associated with actively transcribed genes. 
Histone acetylation facilitates transcription factor binding to the DNA elements by 
increasing DNA accessibility. The acetyl groups could neutralize the positive charge 
of lysine residues in histones, thereby weakening charge-dependent interaction 
between histones and nucleosomal DNA as well as linker DNA or adjacent histones. 
Pore-forming toxins from Listeria monocytogenes, Clostridium perfringens and 
Streptococcus pneumonia induce a dramatic dephosphorylation of histone 3 and 
deacetylation of histone 4, which correlates with a reduced transcriptional activity of a 
subset of host genes, including key immunity genes(Hamon et al., 2007). It has been 
further demonstrated that dephosphorylation of histone 3 induced by the Listeria 
monocytogenes toxin listeriolysin O (LLO) and other pore-forming toxins is K+ 
efflux-dependent (Hamon and Cossart, 2011). In our study, it has been shown that 
UPEC dramatically deacetylate histone 3 and histone 4 in Sertoli cells (Figure 21), 
and in the uroepithelial cell line 5637 (Figure 25B), suggesting that UPEC infection 
might modulate the gene expression profile through histone modifications. Moreover, 
the acetylation of histone 3 and 4 also decreased in the UPEC-elicited orchitis model 
(Figure 22), which strongly indicates that UPEC could manipulate host gene 
expression by histone deacetylation. Furthermore, ChIP analysis data demonstrate that 
deacetylation of histone 4 in the BIM promoter region is associated with the 
suppression of BIM expression after UPEC infection. Therefore, UPEC can induce 
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global deacetylation of histone 3 and 4 in addition to specific deacetylation of histone 
4 in the BIM promoter region, the latter being the mechanism for UPEC-mediated 
BIM suppression. 
 
   In spite of this progress, the underlying mechanism by which UPEC change the 
global histone acetylation status still remains elusive. Histone acetylation was 
catalyzed by histone acetyltransferases (HATs) utilizing acetyl-coenzyme A (acetyl-
CoA) as an essential cofactor to provide an acetyl group to the target lysine residue 
(Choudhary et al., 2014). Opposite, histones are deacetylated by histone 
acetyltransferases (HDACs). One possible explanation of UPEC-mediated global 
histone deacetylation is that UPEC could activate HATs or inhibit activity of HDACs, 
a hypothesis which needs further investigation. Furthermore, it has been shown that 
the increase of histone acetylation in response to growth factor stimulation is 
dependent on ATP-citrate lyase (ACLY), which could convert glucose-derived citrate 
into acetyl-CoA (Wellen et al., 2009). Moreover, recently Lee and coworkers have 
reported that histone acetylation levels are determined in part by changes in acetyl-
CoA availability, and glucose restriction could induce a decrease of histone 
acetylation (Lee et al., 2014). In this context, AKT-mediated ACLY activation could 
promote histone acetylation and UPEC-mediated AKT inhibition could be another 
underlying reason for the observed global histone deacetylation in this study. It has 
been further confirmed that UPEC-mediated AKT inhibition consequently leads to 
ACLY suppression in 5637 cells (Figure 25A). Moreover, HDM (do not inhibit AKT 
activity) are unable to decrease acetylation of histones as shown in Figure 21B. Taken 
together, these results suggest that UPEC-mediated AKT/ACLY inhibition is required 
to induce deacetylation of histone 3 and 4. Acetate can be catalyzed in acetyl 
coenzyme A independent of ACLY activity. It therefore has been hypothesized that 
acetate could rescue histone deacetylation following UPEC infection. As it is shown 
in Figure 25B, UPEC-mediated deacetylation of histone 3 and 4 was rescued by 
adding acetate 2 h post infection. Moreover, it has been demonstrated recently that 
acetate could promote histone acetylation in a dose-dependent manner via an increase 
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in the acetyl-CoA level, which influences early differentiation of embryonic stem cells 
(Moussaieff et al., 2015). Collectively, UPEC-mediated inhibition of AKT/ACLY 
activity, which may further lead to a decrease in the acetyl-CoA level, induces 
deacetylation of histone 3 and 4. Of note, deacetylation of histones can be rescued by 
adding acetate to the culture media.  
 
   In conclusion, the present study demonstrates that UPEC could suppress the AKT 
survival signaling pathway both in vivo (in a UPEC-elicited rat epididymo-orchitis 
model) and in vitro (in isolated rat Sertoli cells), consequently resulting in activation 
of FOXO transcription factors. In parallel, UPEC-mediated AKT/ACLY inhibition 
could induce global deacetylation of histone 3 and histone 4 leading to an epigenetic 
suppression of expression of the FOXO target gene BIM by histone modifications in 
the Bim promoter region. This explains why BIM expression is inhibited, whilst 
paradoxically the AKT/FOXO signaling pathway is active at the same time (Figure 
26). Systemically, during infection UPEC induces BIM suppression to prevent 
apoptosis as a default response of the host to remove infected cells in a controlled 
fashion. Hence, UPEC epigenetically manipulate host cell gene expression involved 
in death pathways to facilitate its survival and dissemination. 
 
                                                                                                                DISCUSSION 
- 92 - 
 
 
Figure 26: UPEC epigenetically suppress the FOXO target gene BIM expression associated with 
apoptosis resistance of infected cells. 
                                                                                                                   SUMMARY 
- 93 - 
 
5 SUMMARY 
 
   Urinary tract infections caused by uropathogenic Escherichia coli (UPEC) 
pathovars belong to the most frequent infections in humans. In men, pathogens can 
also spread to the genital tract via the continuous ductal system, eliciting bacterial 
prostatitis and/or epididymo-orchitis. Upon infection, activation of host cell death 
pathways is an intrinsic mechanism to eliminate the invading pathogens, conversely 
pathogens have evolved multiple strategies to manipulate host cell death pathways to 
propagate, replicate, and evade the host innate immune response. In light of the 
established observation that UPEC can manipulate intracellular signaling pathways to 
subvert innate immune responses, we sought to uncover if this pathogen is also able to 
interfere with the host cell death pathways. Here, it has been shown that the UPEC 
virulence factor alpha-hemolysin abrogates activation of the host cell pro-survival 
AKT signaling pathway depending on extracellular calcium. Inactivation of the AKT 
signaling pathway is further characterized by activation of the AKT-dependent FOXO 
family signaling pathway. Activation of FOXO1 and FOXO3 transcription factors 
were documented by their dephosphorylation and nuclear accumulation in testicular 
Sertoli cells. Although dephosphorylated FOXO was localized in the nuclei of Sertoli 
cells and showed increased DNA-binding activity following UPEC infection, no 
change in the expression levels of FOXO target genes such as BIM were observed. 
UPEC can suppress BIM expression induced by LY249002, a potent inhibitor of 
PI3Ks, which results in attenuation of caspase 3 activation and blockage of apoptosis. 
Mechanistically, UPEC-mediated AKT/ACLY inhibition could induce global 
deacetylation of histone 3 and histone 4, leading to an epigenetic suppression of 
expression of the FOXO target gene BIM by histone modifications in the Bim 
promoter region. In addition, no alteration was documented in the DNA methylation 
status. Taken together, these results suggest that UPEC can epigenetically silence BIM 
expression, a molecular switch that prevents apoptosis. 
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6 ZUSAMMENFASSUNG 
 
   Durch uropathogene Escherichia coli (UPEC) verursachte Harnwegsinfektionen 
gehören zu den häufigsten Infektionen beim Menschen. Bei Männern können die 
Erreger über das kontinuierliche Gangsystem auch auf den Genitaltrakt übergreifen 
und eine bakterielle Prostatitis und/oder Epididymoorchitis auslösen. Dabei stellt ein 
kontrollierter Zelltod durch Apoptose einen Mechanismus des Wirts dar eindringende 
Pathogene zu eliminieren. Umgekehrt haben die Mikroben Überlebensstrategien 
entwickelt, sich einer gegen sie gerichteten Immunantwort durch Manipulation 
intrazellulärer Signalwege zu entziehen. Aufgrund dessen war es das Ziel dieser 
Arbeit zu klären, ob UPEC auch in der Lage sind, die Zelltodwege des Wirts auf 
molekularer Ebene zu beeinflussen. Dabei hat sich gezeigt, dass der UPEC 
Virulenzfaktor alpha-Hämolysin die zum Überleben der Wirtszelle notwendige 
Aktivierung des AKT Signalwegs in Abhängigkeit von extrazellulärem Calcium 
aufhebt. Die Inaktivierung des AKT-Signalwegs ist durch eine Aktivierung des AKT-
abhängigen Signalwegs der FOXO Transkriptionsfamilie gekennzeichnet. Eine 
Aktivierung von FOXO1 und FOXO3 wurde anhand einer Dephosphorylierung der 
FOXOs und folgender Akkumulation der Transkriptionsfaktoren im Zellkern von  
Sertoli-Zellen des Hodens gezeigt. Obwohl FOXO nach Infektion neben der 
nukleären Translokation auch eine erhöhte DNA-Bindungsaktivität in den Kernen der 
Sertoli-Zellen aufwies, konnte keine Änderung der Expression von FOXO-Zielgenen, 
wie z. Bsp. BIM, gefunden werden. Zudem kann UPEC die durch den potenten PI3K 
Inhibitor LY249002 induzierte BIM Expression unterdrücken. Daraus resultiert eine 
abgeschwächte Caspase-3-Aktivierung und folglich Blockade des Zelltods durch 
Apoptose. Mechanistisch kann die UPEC-vermittelte AKT/ACLY-Hemmung eine 
globale Deacetylierung von Histon 3 und Histon 4 hervorrufen, was durch Histon-
Modifikationen in der Bim-Promotorregion zu einer epigenetischen Unterdrückung 
der Expression des FOXO Zielgens BIM führt. Darüber hinaus wurde keine 
Veränderung im DNA-Methylierungsstatus dokumentiert. Zusammengenommen 
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legen diese Ergebnisse nahe, dass UPEC epigenetisch die Expression von BIM 
unterdrücken kann. Durch diese molekulare Manipulation der infizierten Wirtszelle 
wird ein Zelltod durch Apoptose verhindert. 
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